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Abstract 
Many plant-derived secondary metabolites have interesting biological activities and 
some plant compounds such as artemisinin (antimalarial) and vincristine (anticancer 
agent) are the active principles of main-stream pharmaceuticals. South Africa has an 
immense biodiversity and there are in the order of 25 000 indigenous plant species in 
the country. The phytochemistry of many of these plants has never been investigated. 
Many bioactive compounds have been isolated from the Thymelaeaceae, such as 
prostatin (potent anti-HIV agent) and antitumour diterpenoids. Although a large number 
of  Thymelaeaceae species are indigenous to South Africa, only a limited number of 
species have been subjected to phytochemical investigations. Dais cotinifolia L. is one 
species on which phytochemical results have not been published and this tree was the 
subject of this investigation. 
Four compounds were isolated from D. cotinifolia. Three of these compounds are known 
metabolites, two furofuran lignans, kobusin and eudesmin, and the flavonoid catechin. 
A fourth compound is novel norlignan, 2-hydroxy-5-(3-methoxyphenyl)-1-(4-
methoxyphenyl)pentan-1-one. 
The compounds were isolated by applying different chromatographic procedures, such 
as column chromatography, preparative centrifugal thin-layer chromatography and 
semi-preparative high-performance liquid chromatography. The structural elucidation of 
the compounds was based on mass spectrometry and nuclear magnetic spectroscopy. 
The antioxidant activities of the crude extracts of the different plant parts were 
determined by the DPPH assay. In comparison with ascorbic acid, the crude extracts 
only had mild antioxidant activities. The mild activities of the extracts can be explained 
by the fact that three of the compounds isolated are aromatic compounds, but have 
methoxy substituents and not free phenolic groups, which are often associated with 
high-antioxidant activity. 
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Chapter 1: Introduction and Aim 
1.1 Traditional Medicine/Medicinal Plants 
The field of traditional medicine stimulated research on natural products (NPs) and drug 
discovery. Traditional medicine arises from the knowledge, skills, and practices based 
on beliefs and experiences that are native to various cultures and it is utilised for 
prevention, diagnosis, and treatment of multiple ailments (Benzie and Wachtel-Galor, 
2011). Plants, medicinal plants in particular, have played a significant role in advancing 
traditional medicine systems (Koleva et al., 2002). Medicinal plants are a class of plants 
used in herbalism and they contain compounds that are usually extracted for therapeutic 
purposes, and these compounds can be located in various parts of the plant (Mehta et 
al., 2010). Traditional medicine mostly comprises of herbs, herbal preparations, and 
finished herbal products, which have either active plant ingredients or plant materials or 
both (Crouch et al., 2006). Herbs include chopped or powdered plant material such as 
leaves, bark, roots, seeds, flowers, stems, and rhizomes (Crouch et al., 2006). Herbal 
preparations can be either extracts or essential oils from plant material, and these are 
produced by extraction, fractionation, purification and other procedures. Finished herbal 
products are simple herbal preparations made from one or more herbs (Scartezzini and 
Speroni, 2000). Traditional medicine helps mend the medical gap between developed 
and developing countries since it is more affordable to most people. The only downfall 
of traditional medicine is that information is based solely on empirical grounds, and there 
are often no scientific validations (Peteros and Uy, 2010). 
In China, traditional medicine is referred to as "Traditional Chinese Medicine (TCM)" and 
has existed for over 3000 years. The first herbal text in the world was compiled in China 
about 2000 years ago (Benzie and Wachtel-Galor, 2011). TCM produced the three top-
selling botanical products, Ginkgo biloba L., Allium sativum (garlic), and Panax ginseng, 
which are used to treat various diseases (Benzie and Wachtel-Galor, 2011). In the 
Philippines, medicinal plants are regarded as one of their ‘living treasures’ (Peteros and 
Uy, 2010). Out of 13 500 plant species that are found in the Philippines, 1 500 are 
medicinal, but only 120 of them have been studied for safety and efficacy (Peteros and 
Uy, 2010). About 90% of the African population and 70% of the people in India depend 
solely on traditional medicine for primary health care needs (Benzie and Wachtel-Galor, 
2011). In Africa, traditional medicine is the oldest and most diverse medicine system 
(Watt and Breyer-Brandwijk, 1962). Africa is considered as one of the continents with 
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biological and cultural diversity with marked regional differences in healing practices. 
Nonetheless, African medicinal plants are threatened due to deforestation (Koleva et al., 
2002). In early years, people in the United States of America adopted traditional 
remedies, but during the 20th century the safety and efficacy of herbs and botanicals 
were questionable and due to that herbal medicine was rejected (Yadav and Agarwala, 
2011). However, plants are still regarded as a source of pure chemical compounds in 
the development of medicine (Yadav and Agarwala, 2011). In Europe, a growing trend 
has been observed towards the use of traditional medicine along with pharmaceutical 
drugs. In Germany alone, it is estimated that 90% of the people use herbal medicines 
(RBGK, 2017).  
Medicinal plants contain a diverse collection of secondary metabolites with various 
functions like defence against herbivores, diseases, and parasites (Peteros and Uy, 
2010). These chemicals often have complex chemical structures that are not available 
in synthetic compound libraries. Botanic Gardens Conservation International estimates 
that there are about 400 000 plants worldwide (BGCI, 2017) and only about 28 000 are 
considered as medicinal plants (RBGK, 2017). Furthermore, just 5-20% of these species 
have been investigated for general usefulness or biologically active compounds (Peteros 
and Uy, 2010). The potential of using plants as a source of compounds that are used for 
drugs production has been proven, for example, by paclitaxel, isolated from Taxus 
brevifolia Nutt., which is used for lung, ovarian and breast cancer  (Gurib-Fakim, 2006). 
This has prompted researchers worldwide to investigate different species and their 
therapeutic principles (Richards and Sharma, 1991). In some countries, traditional 
medicine is now being integrated into mainstream healthcare systems. In December 
2016, the Chinese Government announced that by 2020 TCM would be incorporated 
into their healthcare system (RBGK, 2017).  
1.2 Traditional Medicine in South Africa 
The use of plants in traditional medicine in South Africa is well documented. A treatise 
on southern Africa was published by Watt and Breyer-Brandwijk in 1962. Hutchings and 
co-workers compiled an inventory of nearly 1000 Zulu medicinal plants (Hutchings et al., 
1996) and Van Wyk et al. (2009) described the ethnobotany and pharmacology of more 
than 150 plant species used in traditional medicine.  
Medicinal plants are marketed in two separate ways in Southern Africa, i.e. a formal and 
an informal system. The formal market system includes herbal remedies, nutraceuticals, 
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phytomedicines, and cosmeceuticals, while the informal market system focuses entirely 
on traditional medicines and herbal remedies (Crouch et al., 2006).   
Southern Africa is one of the most diverse floristic regions in the world. It is estimated to 
have over 30 000 plant species and 1 000 of these are traded in informal markets, but 
only 5% are traded formally. Below (Table 1.1) is a list of some popular medicinal plants 
used in South Africa (Crouch et al., 2006). 
1.3 Natural Products 
NH2
CH3
+ HN
NH2
H3C O
NH2
Lisdexamfetamine (1.3)L-LysineD-Amphetamine
NH2
O
NH2
HO
 
Scheme 1.1. Lisdexamfetamine a hybrid molecule of dextroamphetamine and the 
amino acid L-lysine. 
Natural products (NPs) are secondary metabolites derived from natural sources such as 
plants, animals, and microorganisms (Cragg et al., 1997). Secondary metabolites are 
compounds that are not essential for the growth, development, or reproduction of an 
organism. NPs have been a significant source of chemical diversity for starting materials 
in organic synthesis and have also been influential in the discovery of pharmaceuticals 
for over a 100 years (Firn and Jones, 2003). Back in history, pharmaceutical companies 
have been using plant extracts to form relatively crude therapeutic formulations. 
However, formulation of pure compounds became the norm with the advancement of 
antibiotics in the mid-twentieth century (Mishra and Tiwari, 2011). There are 1562 new 
drugs that came on the market in the United States from 1981 – 2014, 67 (4%) are 
unaltered natural products, 9 (1%) are botanical drugs (herbal extracts), 320 (21%) are 
natural product derivatives, 61 (4%) are synthetic compounds with NP pharmacophors 
and 334 (21%) are synthetic compounds that mimic natural products, i.e. in total 51% of 
these drugs are NPs or have their origin in NPs (Newman and Cragg, 2016).   To mention 
one, Sativex® is a mixture of dronabinol (1.1) and cannabinol (1.2) and this drug is an 
analgesic for severe pain used by advanced cancer patients. Lisdexamfetamine 
(Scheme 1.1),   a hybrid molecule of dextroamphetamine and the amino acid L-lysine, 
is used as a prodrug of dextroamphetamine used for the treatment of attention deficit 
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hyperactivity disorder (ADHD) and binge eating disorder (Luqman and Pezzuto, 2010) 
(Figure 1.1).  
O
OH
CH3
Dronabinol (1.1)
OH
CH3
CH3H2C
Cannabinol (1.2)
HO
 
Figure 1.1. Some natural product-derived drugs. 
1.4  Phytochemicals 
Plants produce a large number of chemical compounds (phytochemicals) (Crouch et al., 
2006). These compounds are produced to ensure the survival of the plants by providing 
preventive properties against parasites and herbivores (Crouch et al., 2006). In higher 
plants, these phytochemicals are classified as alkaloids, coumarins, steroids, lignans, 
flavonoids, terpenoids and tannins, amongst others (Peteros and Uy, 2010). Almost 50% 
of drugs derived from NPs are plants based. However, only a tiny fraction of plants have 
been studied for their chemical and pharmacological properties (Richards and Sharma, 
1991). Figure 1.2 shows examples of some of the classes of secondary metabolites that 
are frequently found in plants and they are discussed in detail below. 
N
O
H3C
O O O HO
OH
H
H
O
OH
LignanSteroidCoumarinAlkaloid  
 
F l a v o n o i d 
O O H 
N e r o l a t e r p e n o i d 
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O O
O
O
O
O
O
O
O
O
O
HO
OH
HO
OH
OH
OH
OH
OH
OH
HO
OH
OH
HO
HO
OH
Pentagalloylglucose, a hydrolysable tannin  
Figure 1.2. Some classes of natural products that are frequently found in plants. 
1.4.1 Alkaloids 
Alkaloids were first introduced in the 19th century by Carl Friedrich Wilhelm Meisner 
(Bruneton, 1999). They are defined as natural substances that react like bases, but there 
is no exact definition for alkaloids, and it is also difficult to distinguish them from other 
natural nitrogen-containing metabolites (Bruneton, 1999). However, the simplest way of 
identifying them is that the nitrogen is part of the heterocyclic structure and that they are 
derived from amino acids (Bruneton, 1999). Even though alkaloids are regarded as 
nitrogen-containing organic compounds, simple amines and peptides are not considered 
as alkaloids (Roeder and Wiedenfeld, 2011). Nonetheless, from a different perspective, 
alkaloids are regarded as a cyclic organic compound that possesses a nitrogen atom in 
its negative oxidation state (Bruneton, 1999). According to this definition amines, amides 
and quaternary ammonium are included but nitrate derivatives are excluded (Bruneton, 
1999). Alkaloids consist of complex structures and due to the presence of nitrogen atoms 
they often have significant pharmacological activity (Bruneton, 1999). One example of 
an alkaloid is nitidine (1.4) (Figure 1.3), which is known to have antimalarial 
(antiplasmodial) activity (Bouquet et al., 2012). 
N
O
O
O
O
H3C
H3C
Nitidine (1.4)  
Figure 1.3. Structure of nitidine, an alkaloid. 
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Table 1.1. Some popular medicinal plants of southern Africa. 
Scientific name  Common 
name  
Zulu name  Traditional/Medicinal uses 
Alepidea 
amatymbica Eckl. & 
Zeyh. 
(Apiaceae) 
Giant 
Alepidea 
iKhathazo/ iQwili The plant is extensively used for the treatment 
of tuberculosis. The rhizome is carried as a 
charm and is also used for colds, asthma, 
chest pain and influenza (Crouch et al., 2006) 
Artemisia afra 
Jacq. ex Willd. 
(Asteraceae) 
African 
wormwood 
uMhlonyane The plants are used for the treatment of 
respiratory tract infections, indigestion, fever, 
cold, influenza, sore throats, asthma, 
pneumonia, gout, and malaria (Crouch et al., 
2006). 
Bersama tysoniana 
Oliv. 
(Melianthaceae) 
Common 
white ash 
isiNdiyandiya/ 
uNdiyaza 
The bark of the plant is used as the sniffing 
powder for the treatment of headaches and 
sinus congestion. The plant is also used in the 
treatment of snakebites (Crouch et al., 2006). 
Bowiea volubilis 
Harv. ex Hook.f. 
(Hyacinthaceae) 
Climbing lily iGibisila/ iGuleni The plant is used to treat bladder problems, 
sterility in women and tissue swelling which is 
caused by the accumulation of fluid (Crouch et 
al., 2006). 
Combretum caffrum 
(Eckl. & Zeyh.) 
Kuntze 
(Combretaceae) 
Cape 
bushwillow  
uMdubu The Xhosa people use the roots of the plant to 
soothe body pain, while Zulu people use root 
bark as a malicious charm. The plant contains 
a compound called combretastatin, which has 
strong anticancer properties. This compound is 
under development as an anticancer drug 
(Crouch et al., 2006).  
Cryptocarya latifolia 
Sond. 
(Lauraceae) 
Broad-leaved 
quince/ 
Bastard 
stinkwood 
uMkhondweni/ 
uNdlangwenya 
The bark of the plant is used to treat chest 
pains, headaches, stomach ailments and 
bladder diseases (Crouch et al., 2006).  
Dioscorea dregeana 
(Kunth) T.Durand & 
Schinz 
(Dioscoreaceae) 
Wild yam isiDakwa The tuber of the plant is used as a sedative for 
treating insane people. Adding small pieces of 
tuber to beer is claimed to increase the 
strength of the beer. The plant is also used to 
treat sores, fits, wounds and also to facilitate 
childbirth (Crouch et al., 2006).  
Drimia robusta 
Baker 
(Hyacinthaceae) 
Satin squill isiKlenama/ 
iNdongana-
zimbomvana 
The bulb is used for relieving pain, feverish 
cold, coughs, and as a heart tonic (Crouch et 
al., 2006). 
Elaeodendron 
transvaalense 
(Burtt Davy) 
R.H.Archer 
(Celastraceae) 
Transvaal 
saffron  
uMgodudo/ 
iNgwavuma 
The bark of the plant is used as an emetic to 
strengthen the blood of men to improve their 
sexual ability. Bark infusions are used in the 
treatment of stomach cramps and diarrhoea 
(Crouch et al., 2006). 
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Eriospermum 
mackenii 
(Eriospermaceae) 
Yellow fluffy 
seed  
iNsulansula/ 
iNcamashela/ 
uMathintha 
The tuber is used in the treatment of diarrhoea 
by means of an enema (Crouch et al., 2006). 
Gasteria croucheri 
(Hook.f.) Baker 
(Asphodelaceae) 
Gasteria iMpundu The plant is used in the treatment of 
rheumatoid pains by either application as an 
enema or by washing the painful area. The 
leaves of the plant are used to treat paralysis. 
The plant can also be sprinkled around the 
household to prevent conflict (Crouch et al., 
2006). 
Hypoxis 
hemerocallidea 
Fisch., C.A.Mey. & 
Avé-Lall. 
(Hypoxidaceae) 
African 
potato/ Star 
flower 
iLabatheka/ 
iNkomfe 
The tuberous rootstock is used for the 
treatment of headaches, mental disorders, 
dizziness, cancers, inflammation, and HIV-
AIDS (Crouch et al., 2006).  
 
1.4.2 Coumarins 
Coumarins are heterocyclic molecules that have been intensely studied due to their 
biological activities (Zhang et al., 2017). Apart from that, coumarins also have favourable 
photophysical properties (Zhang et al., 2017). Coumarins have been used as potential 
fluorescence materials and emissive dopants in organic light-emitting diode (OLEDs) 
applications (Yu et al., 2010). Their derivatives are regarded as a new class of 
antituberculosis candidates, and also possess other pharmacological properties like 
anticancer (Sashidhara et al., 2010), antiproliferative, anti-HCV, anti-HIV, antimalaria  
(Kadhum et al., 2011), antioxidant, antibacterial, antifungal, and anti-Alzheimer activities 
(Hu et al., 2017). Some coumarins-based derivatives are acenocoumarol (1.5), 
dicoumarolum (1.6), warfarin (1.7), hymecromone (1.8) and carbocromen (1.9) (Figure 
1.4) (Hu et al., 2017).  
 
 
 
 
 
O
OH
O
O NO2
Acenocoumarol (1.5)
O O OH
OH
OHO
OH
Dicoumarolum (1.6)
O
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Figure 1.4. Some examples of coumarins. 
1.4.3 Steroids 
Steroids are one of the largest group of secondary metabolites (Bruneton, 1999). 
Steroids, in general, arise from the mevalonate pathway and plant steroids arise from 
squalene-like triterpenes (Bruneton, 1999). The plant steroids have a similar mechanism 
(act as architectural components of membranes) to that of triterpenes except that theirs 
is specific to plants (Bruneton, 1999). This applies to steroidal alkaloids (1.10), 
cardenolides (1.11), phytosterols (1.12), and saponins (1.13) (Figure 1.5) (Bruneton, 
1999) (Figure 1.5). Steroids exhibit biological activities, especially the nitrogen-
containing steroidal compounds (Martínez-Pascual et al., 2017). These compounds 
have several biological activities such as anti-inflammatory (Huang et al., 2012), 
antiparasitic, antifungal, and antitumour activity (Krojer et al., 2013). Steroidal lactams 
have antiproliferative, antileukemic, and antifungal activities (Martínez-Pascual et al., 
2017).  
 
   
 
 
 
 
 
 
O O
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N
H
HO
H
H
H
H
H
Steroidal alkaloid - solanidine (1.10)
HH
HO
Phytosterols - beta-sitosterol (1.12)
H
H
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Figure 1.5. Some examples of steroids. 
1.4.4 Flavonoids 
Flavonoids are phenolic compounds that are found in plants and fungus, and some 
beverages such as tea and wine (Gonyela, 2016). They consist of different skeletons, 
either flavone, isoflavone or neoflavone based and are commonly polyphenolic (Mouri 
et al., 2014). There are about 4000 flavonoids that have been identified so far (Dengada, 
2014). They possess a variety of biological activities including antifungal, antibacterial, 
antiviral, antioxidants, anti-inflammatory, antiproliferative and anti-allergenic properties 
(Feyen et al., 2007). Due to their diverse structural patterns, flavonoids are regarded as 
a rich source of compounds with good anticancer potential. Some flavonoids are also 
known to inhibit angiogenesis by blocking cell cycle-induced apoptosis and disrupting 
mitotic spindle formation (Mouri et al., 2014). 
1.4.5 Terpenoids 
Terpenoids are one of the largest groups of natural secondary metabolites (Bruneton, 
1999), and they are produced by nearly all life forms (Xie et al., 2017). There are over 
15 000 structures of terpenoids that have been elucidated, however, the exact number 
of terpenoids that exist in nature is still unclear (Bian et al., 2017). Some examples of 
terpenoids (Figure 1.6) are paclitaxel (1.15), an important anticancer drug, artemisinin 
(1.16), an antimalarial drug, and ginsenoside (1.17) (Figure 1.6), a major component of 
the Chinese traditional medicine ginseng (Bian et al., 2017). In the search for antidiabetic 
compounds, three triterpenoid glycosides were isolated from Centipeda minima; 3′-
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desulfated atractyloside, 15-O-[α-L-rhamnosyl-(1→2)-β-D-glucosyl]grandiflorolic acid, 
and 2α-hydroxylemmonin, which show α-glucosidase inhibitory activity (Nguyen et al., 
2017). 
      
            
 
 
 
                                                                                 
 
 
 
 
 
 
Figure 1.6. Some examples of terpenoids. 
1.4.6 Tannins 
Tannins are secondary metabolites that are widespread in “woody and herbaceous 
plants” (p.1072) with predominant availability in legumes and twigs (Widsten et al., 
2010). Primarily, they are divided into two categories, condensed tannins and 
hydrolysable tannins (Theodoridou et al., 2010). The hydrolysable tannins consist of a 
carbohydrate as the central core (Figure 1.7). Hydrolysable tannins are polyols, glucose 
usually, which are esterified with phenolic acids (Akiyama et al., 1998). These phenolic 
acids are usually gallic acid in gallotannins or hexahydroxydiphenic acid in ellagitannins. 
Hydrolysable tannins  are commonly found in fruit pods and in contrast to condensed 
tannins, their degradation products are absorbed in the small intestines of animals 
(Theodoridou et al., 2010). Condensed tannins are mostly found in forage legumes, 
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trees and shrubs (Theodoridou et al., 2010), and are complexes of oligomers or 
polymers of flavonoid units that are linked by carbon-carbon bonds (Theodoridou et al., 
2010). Both hydrolysable (Figure 1.8) and condensed tannins have bactericidal activity 
against Staphylococcus aureus (Chung et al., 1993). 
Tannic acid
O
OH
O
OH
HO
HO
HO
O
O
O O
O
HO
HO
O
OH
OH
OH
OH
OHO
OH
 
Figure 1.7. Structure of tannic acid, a hydrolysable tannin. 
1.4.7 Lignans 
Lignans are diaryl compounds that are widely distributed to different plants (Milder et al., 
2005). The richest source of lignans is flaxseed; other sources are grains, vegetables, 
fruits and beverages (Shyu and Hwang, 2002). Lignans are a class of NPs that are 
derived from cinnamic acid and they exhibit a variety of biological activities, which 
include antioxidant and anti-oestrogenic properties (Davin and Lewis, 2000). These 
activities are the source of the ability of lignans to reduce the risk of some cancers and 
cardiovascular diseases (Davin and Lewis, 2000). They reduce these diseases by 
interfering with cell division in both animals and humans (Moss, 2000). They also play a 
vital role in the most famous and old traditional medicine; TCM. In TCM lignans are used 
to treat viral hepatitis and as liver protection (Moss, 2000).   
1.5 Problem statement  
Cancer is a group of diseases that are characterised by an uncontrollable growth of cells 
and the spread of abnormal cells (Luqman and Pezzuto, 2010). It is a major public health 
problem in the United States and other countries around the globe (Luqman and 
Pezzuto, 2010). According to statistics of the World Health Organization (WHO) 
published February 2017, cancer is one of the leading causes of morbidity and mortality 
worldwide; it had approximately 14 million new cases in 2014, and the number is 
expected to increase by 70% in 20 years’ time. It is estimated to cause 8 million deaths 
each year, and the number is continuously increasing (Jemal et al., 2008). If the existing 
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trend continues, 1 in 4 people will die of cancer (Luqman and Pezzuto, 2010). The 
economic impact of cancer is significantly rising. According to WHO about 70% of deaths 
from cancer occur in low and middle-income countries (WHO, 2014). In 2010, the sum 
of the annual economic cost of cancer was estimated to be US$ 1.16 trillion.  
Literature shows that there are a number of natural products (NPs) that are available as 
chemoprotective agents against the most commonly occurring cancers around the globe 
(Reddy et al., 2003). Antioxidants, phenols and reactive groups that show protective 
properties are marked as the major groups of these products, these natural products are 
found in fruits, vegetables, plant extracts and herbs (Table 1.2). 
Table 1.2. Chemoprotective products found in fruits, vegetables, plant extracts, and 
herbs. 
Source Active component Mechanism of 
action 
Cancer inhibited  References 
Olives  Polyphenols Antioxidants Various cancers (Langseth, 1995)  
Citrus fruits β–Cryptoxanthin, 
bioflavonoids, 
chalcones, Vitamin 
C 
Antioxidants 
stimulate 
expression of RB 
genes and p73 
gene (a p53 related 
gene)  
Rat tumour, 
various cancers  
(Nishino et al., 
2000) 
Garlic, onions, 
leeks, chives 
Allicin, flavonoids, 
vitamin C, 
selenium, sulfur 
Detoxifies 
carcinogen, inhibits 
Helicobacter pylori, 
cell cycle arrest 
from S to G2M 
boundary phase  
Stomach cancer (Barch et al., 
1996) 
Gymnosporia 
rothiana Laws 
GCE: chloroform 
ether extract 
DNA/RNA and 
protein synthesis 
inhibited after 
treatment for 12-36 
hr 
Leukaemia in 
mice  
(Chapekar and 
Sahasrabudhe, 
1981) 
Scutellaria radix, 
S. indica 
Flavonoids  Prostaglandin E2 
production 
Rat C6 glioma 
cells  
(Nakahata et al., 
1998) 
The mechanism of the protective effect is still unclear. However, there is undeniable 
evidence that the consumption of fruits and vegetables decreases the incidence of 
carcinogenesis (Reddy et al., 2003).  Diet and diseases have been associated since the 
early history of medicine (Mehta et al., 2010). “Let food be thy medicine and medicine 
be thy food," said Hippocrates the father of modern medicine 2 500 years ago (Mehta et 
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al., 2010). Later Galen of Pergamon (129–199 A.D.) who was a Greek physician, 
prescribed different types of food, including barley, and various vegetables for the 
treatment of cancer (Karpozilos and Pavlidis, 2004). Some anticancer NPs can be 
directly isolated from plants, i.e. Daphne genkwa Sieb.et Zucc, a species of the 
Thymelaeaceae family that is known to have a number of compounds, for example 
flavonoids, lignans, coumarins and daphnane-type diterpene esters. All these 
compounds are known to have moderate anticancer activity but the diterpene esters are 
known to have the highest anticancer capacity (Li et al., 2013).  
Human Immunodeficiency Virus (HIV) is a lentivirus that can escalate to acquired 
immune deficiency syndrome (AIDS). HIV was discovered in 1981, and it already caused 
the deaths of 25 million people globally. It is a major threat to humankind to date 
(Kurapati et al., 2016). Nonetheless, the introduction of highly active antiretroviral 
therapy (HAART) has reduced the HIV incidence drastically (Kurapati et al., 2016). The 
natural products that commonly show activity against HIV are prenylated 
benzophenones, guttiferones that are extracted from different genera namely;  Garcinia, 
Symphonia and Clusia (Mzozoyana, 2015). In the Thymelaeaceae family, there is 
Stellera chamaejasme L. that was found to possess anti-HIV compounds (Asada et al., 
2013). The plant has been used in TCM as dermatological and anthelmintic agent 
(Asada et al., 2013). When investigation on HIV agents was conducted on the plant, 
eight compounds were isolated and only two compounds; stelleralide A and gnidimacrin 
which were found to have a very potent anti-HIV activity (Asada et al., 2013). 
Dais L. is one of the smallest genera of the Thymelaeaceae family with only 2 species. 
The phytochemistry of both species in this genus has not been published apart from  a 
conference abstract on Dais cotinifolia L., which reported  that a number of lignans had 
been isolated from this species (Crabtree and Belofsky, 2010). No structures are given 
in this references and no follow-up papers have been published. Nevertheless, there are 
other genera of this family with species with known phytochemistry, like Daphne L. and 
Gnidia L. and these genera are rich in anticancer and anti-HIV compounds (Meruelo et 
al., 1988). The limitation in drug discovery from this family is that some genera are toxic, 
i.e. Gnidia species have diterpene esters which are PKC activators for adjuvant therapy 
towards the eradication of HIV-1 but the downfall is the toxicity of these compounds 
(Meruelo et al., 1988). This family has a potential of producing antiviral and anticancer 
compounds, therefore, it deserves attention since most species of this family that are 
found in South Africa have not been studied. The family is reviewed in depth in Chapter 
2. 
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1.6  Aim and objectives 
Aim 
The aim of this study is to investigate the phytochemistry of the medicinal plant species 
Dais cotinifolia L.  
The research objectives were as follows: 
• Identify and collect the tree material. 
• Extract different parts of the plant with various solvents. 
• Isolate pure compounds from different parts of the tree using DIOL column, 
vacuum liquid chromatography (VLC) column, column chromatography, 
centrifugal thin-layer chromatography (CTLC), HPLC and TLC. 
• Identification and characterisation of the isolated compounds following various 
spectroscopic techniques; NMR (1D & 2D), LC-MS, TOF-MS, and UV.  
• Identification of appropriate bioassays based on classes of the isolated 
compounds. 
• Assaying the compounds for biological activity thereby enhancing further use of 
the plants or validating their ethnomedicinal use. 
1.7  Structure of the thesis 
This thesis is divided into five chapters. Chapter 2 provides an overview of the literature 
of the Thymalaeaceae family and Dais cotinifolia L., it also gives a brief overview of the 
instrumentation that was used during this study. Chapter 3 focuses on the results 
obtained in the investigation  and  Chapter 4 gave the experimental details of the project. 
Chapter 5 is a general conclusion of the study, limitations are discussed and future work 
is proposed. 
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Chapter 2: Literature review 
The plant under investigation in this study, Dais cotinifolia L., is part of the family 
Thymelaeaceae.  This Chapter focuses on the literature of the Thymelaeaceae, some 
genera and species of this family that are used in traditional medicine, and genera that 
exhibit biological activity. In the second part of the Chapter, methods used to isolate pure 
compounds are discussed and spectroscopic methods essential for the structure 
elucidation of pure compounds are briefly reviewed.  
2.1 Thymelaeaceae 
Thymelaeaceae is a medium-sized family of flowering plants that comprises about 900 
species that are divided into around 55 genera, which are widespread in tropical and 
sub-tropical areas (Beyers and Marais, 1998). Thymelaeaceae is classified into four 
subfamilies; Aquilarioideae, Gonystyloideae, Synandrodaphnoideae and 
Thymelaeoideae (Beaumont et al., 2009). Aquilarioideae, Gonystyloideae, and 
Synandrodaphnoideae are small subfamilies and contain seven, three and one genera, 
respectively. The majority of the genera are classified under Thymelaeoideae, including 
the largest genus Gnidia (140 species). 
In Africa alone, there are more than 40 genera of Thymelaeaceae (Ferrari et al., 2000), 
including Dais, Dicranolepis, Craterosiphon, Englerodaphne, Gnidia, Lachnaea, 
Lasiosiphon, Octolepis, Peddiea, Struthiola, Synandrodaphne, and Synaptolepis 
(Oladipo and Oyaniran, 2013). However, some of the genera in this family, such as 
Gnidia and Pimelea, need revision because of uncertain generic circumscription (Maurin 
et al., 2013). The key problem is the classification within the subfamily Thymelaeoideae 
(Maurin et al., 2013). The largest genera in this family are discussed in detail below. 
Dais has only two species, but it is included since it is the plant of interest in this study. 
In Figure 2.1 a graph listing some genera of the Thymelaeaceae and the number of 
species in each genus, is given. 
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Figure 2.1. Some genera of the Thymelaeaceae. 
2.1.1 Gnidia L. 
The genus Gnidia L. was established by Linnaeus in 1753, when the genus had only 
three species (Beaumont et al., 2009). Gnidia is one of the genera of the subfamily 
Thymelaeoideae of Thymelaeaceae  (Franke et al., 2002) and comprises about 140 
species  (Beaumont et al., 2009). This genus is also known to be polyphyletic and, 
therefore, needs to be reclassified  (Boatwright et al., 2017). Many species in this genus 
are used in African traditional medicine (ATM) to treat ailments such as a sore throat, 
abdominal pain, wounds, and burns (Franke et al., 2002). Gnidia species are known to 
contain daphnane-type diterpene esters that possess antineoplastic activity (Mothana 
and Lindequist, 2005). Phytochemical investigations that were conducted on species of 
this genus identified coumarin, lignans, flavonoids and benzophenone glycosides in this 
genus (Franke et al., 2002).   
 Gnidia glauca Fresen. is used to treat sore throats, abdominal pain, wounds, burns, 
snake bites, contusions, swellings, backache and joint ache (Ghosh et al., 2012). G. 
glauca has been recently reported to have compounds with antidiabetic properties 
(Ghosh et al., 2012).  The stem, leaf and flower extract of G. glauca were assayed for 
inhibition of  porcine pancreatic α-amylase and glucosidases from pancreas, liver, and 
small intestine of Swiss mice, extracts were found to have a high inhibition of α-amylase 
(Ghosh et al., 2012). The results provided evidence that G. glauca has anti-diabetic 
activity (Ghosh et al., 2012). The compounds that have been isolated from this plant are 
gnidilatin 20-palmitate (2.4), gnidilatidin 20-palmitate (2.7), gnidilatin (2.5) and 
gnidilatidin (2.6) (Kiptoon et al., 1982) (Figure 2.2). 
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Gnidia latifolia and Gnidia glaucus have activity against leukemia (Kupchan et al., 1976). 
G. latifolia also has piscicidal activity (Kupchan et al., 1976). Another species in this 
genus is Gnidia socotrana, which is endemic to Socotra Island (Franke et al., 2002). 
When phytochemical studies were conducted on the leaves and twigs of the plant,  six 
novel compounds were identified, i.e. a biscoumarin (2.3), two novel umbelliferyl-
flavonoids and three other compounds with a spiro-bis-γ-lactone structure (Franke et al., 
2002). Gnidia lamprantha contains predominantly diterpenoid daphnetoxins with 
antitumour activity (Ferrari et al., 2000). Compounds isolated from this plant include 
gnididin (2.2) and huratoxin (Kupchan et al., 1976). The compounds that were isolated 
from Gnidia latifolia were similar to that of G. lamprantha except for some 
sesquiterpenoids  (Kiptoon et al., 1982). The roots of Gnidia involucrata Steud. ex A. 
Rich, along with other Thymelaeaceae species, are used in Zimbabwe to reduce the 
virginal orifice (Ferrari et al., 2000). When phytochemical studies were conducted on G. 
involucrate, six compounds were obtained and identified as 2,3,4,5,6-
pentahydroxybenzophenone-4'-C-glucoside (2.1), 2,4',6-trihydroxy-4-
methoxybenzophenone-2-O-glucoside, mangiferin, kaempferol-3-O-glucoside, 
yuankanin and manniflavanone (Ferrari et al., 2000). Furthermore, the roots of the plant 
are also internally used in Ethiopia as laxatives and vermifuge (Borris et al., 1988). In 
some African countries like Nigeria, Congo, Zimbabwe, Malawi and Sudan they Gnidia 
kraussiana Meissn. is used as a source of hunting and fish poisons  (McGaw and Eloff, 
2008). 
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Figure 2.2. Some of the compounds isolated from Gnidia species. 
2.1.2 Pimelea Banks & Sol. ex Gaertn. 
Pimelea (Thymelaeoideae subfamily) originates in Australia and consists of about 110 
species. It is now widespread in Lord Howe Island, New Zealand, and Timor, with about 
90 species endemic to inland Australia (Silcock et al., 2012). Pimelea is closely related 
to Thecanthes (a small genus with about five species in total) (Motsi et al., 2008). 
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Pimelea linofolia (P. linofolia) and Pimelea ligustrina (P. ligustrina) are native to the east 
coast of Australia (Tyler and Howden, 1981). Extracts from these two species have 
anticancer activity. Nevertheless, the compounds associated with this activity were not 
successfully identified from these species but two compounds (linifolins A and B) with 
piscicidal activity were identified (Tyler and Howden, 1981). The name of linifolin A was 
later changed to linimacrin A and linifolin B to pimelea factor P3 (Tyler and Howden, 
1985). Many species in this genus are reported to be poisonous when ingested, for 
example, P. altior F. Muell., P. decora Domin, P. elongata Threlfall, P. flava R. Br., P. 
glauca R. Br., P. haematostachya F. Muell., P. linifolia Sm., P. microcephala R. Br., P. 
pauciflora R. Br., P. simplex F. Muell., P. trichostachya Lindl, P. neo-anglica Threlfall 
and P. prostrata Willd. (Silcock et al., 2012).  Among the species above, three species 
cause most of the problems and these are P. trichostachya, P. simplex and P. elongate. 
However, the mechanism of poisoning is still unclear (Silcock et al., 2012). Although 
most species in this genus are poisonous, there are species that possess anti-neoplastic 
activity, and these are P. linifolia (Smith and Towers, 1985), P.  ligustrina, and P. simplex 
(Tyler and Howden, 1985). The compounds that are responsible for the antineoplastic 
activity are gnidimacrin (2.9) from P. ligustrina, simpleximacrin (2.8) from P. simplex, 
linimacrin D (2.10)  and pimelea factor P3 (2.11) from P. linifolia (Tyler and Howden, 
1985). Figure 2.3 below shows some of the compounds that were isolated from different 
Pimelea species. 
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Figure 2.3. Compounds present in Pimelea species. 
2.1.3 Daphne L. 
The genus Daphne comprises about 100 species (Khodadadian et al., 2016), 
widespread across Europe, Asia, Africa, and Australia  (Noshad et al., 2009). Forty-four 
of these species occur in China (Zhang et al., 2008) and seven in Turkey (Sanda et al., 
2015). The seven species that are found in Turkey are D. gnidioides Jaub. & Spach., D. 
mezereum L., D. mucronata Royle., D. oleoides Schreb., D. pontica L. and D. serica 
(Sanda et al., 2015).  In various countries, species of Daphne are used as herbal folk 
medicine to treat different ailments (Sanda et al., 2015). The most-used species are 
Daphne oleoides, which is used to treat rheumatic pain, lumbago, and to reduce fever 
(Kupeli et al., 2007), D. genkwa, which is used to treat inflammatory disorders (Zheng 
et al., 2006), D. acutiloba, used for wounds and bruises, D. tangutica, which is used for 
the treatment of rheumatoid arthritis, D. mezerium, which is used for chronic 
rheumatism, skin diseases, gout, and inflammations in the lymph tissue (Chen et al., 
2004), and D. giraldii Nitshe, which is used for the treatment of aches and rheumatism 
(Zhang et al., 2008). Various compounds have been isolated from D. giraldii, to name a 
few, monomeric coumarins (Sun et al., 2006), biscoumarins, flavonoids (Liao et al., 
2005), lignans, phenolic glycosides (2.9), daphnodorin A (2.13), daphnodorin B, 
daphnoretin (2.12), glucogenkwanin (2.14), yuankanin, daphneside (2.15), and 
syringaresinol (2.16) (Zhang et al., 2008). 
  The genus Daphne is prominent for having species used for treatment of cancer since 
the time of Aphodisias (AD 2nd century) (Kupeli et al., 2007). One of the species that is 
used to treat cancer is D. mucronate Royle., which is indigenous to Iran (Khodadadian 
et al., 2016). Daphnodorins (flavonoids), which were isolated from the roots of D. 
genkwa, have antitumour activity (Zheng et al., 2007). The flower buds of this species 
were used against mammary cancers (Zheng et al., 2006). D. mezereum was also 
reported to have anticancer activity (Kupeli et al., 2007). The extracts of D. gnidioides 
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and D. pontica were found to be an excellent source of natural antioxidants for both 
medicinal and food applications (Sanda et al., 2015). The secondary metabolites that 
are usually isolated from Daphne species are flavonoids, coumarins and diterpenoids 
(Sanda et al., 2015). Figure 2.4 shows some compounds that were isolated from Daphne 
species. 
     
O
O
HO
HO
O
OH
OH
Daphnodorin A (2.13)
HO
HO
 
OH
O
O
O
CH3
OH
O
OH
HO
O
OHO
HO
OH
Glucogenkwanin (2.14)
OH
  
O OO
O
O
HO OH
OH
O
HO
HO
OH
Daphneside (2.15)
HO
OH
 
O
O
H
H
OH3C
HO O CH3
O CH3
O
CH3
OH
Syringaresinol (2.16)  
Figure 2.4. Some organic compounds isolated from the genus Daphne. 
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2.1.4 Wikstroemia Endl. 
The genus Wikstroemia comprises about 70 species (Guo et al., 2015). It consist of  
tropical and subtropical shrubs or trees that are distributed in southeast Asia to Malaysia, 
northeast Australia and in the Pacific islands (Gupta and Gillett, 1969). Phytochemical 
investigations conducted on species in this genus have revealed that it has daphnane-
type diterpenoids. These compounds possess a number of biological activities such as 
antitumour, cytotoxic, anti-HIV, pesticide and skin irritant activities (Guo et al., 2015). 
Some compounds that have been isolated from species in this genus are active 
daphnane-type diterpene esters, tiglianes, lignans, bioflavonoids and bicoumarins (2.21) 
(Liao et al., 2006).  Wikstroemia hainanensis Merr., is a shrub that shows anticancer 
activity, and the active compounds were three lignans, wikstrone (2.17), wikstroemol 
(2.18), and wikstroemone (2.19). The three lignans were isolated from the aerial parts 
of the shrub along with twelve known compounds, erythro-guaiacylglycerol-O-4’-sinapyl 
ether, trans-4-hydroxycinnamic acid (2.20), pinoresinol, medioresinol, syringaresinol, 
nortrachelogenin, lariciresinol, ficusesquilignan A, sitosterol, hederagenin, 
umbelliferone, and daphnoretin (Liao et al., 2006). The aforementioned compounds are 
illustrated in Figure 2.5. 
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Figure 2.5. Structures of compounds from the genus Wikstroemia. 
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2.1.5 Daphnopsis Mart. 
The genus Daphnopsist has 65 species. Daphnopsis was first described by Martius and 
Zuccarinil in 1824 and is native to Central America, Antilles and South America (Chang 
et al., 2017). Although different Daphnopsis species have been reported to have 
different medicinal and practical properties, limited phytochemical studies have been 
reported on this genus (Blaskó et al., 1988). Daphnopsis brasiliensis Mart. et Zucc. is 
known to be used to treat psoriasis and also as a purgative (Blaskó et al., 1988). 
Daphnopsis schwartzii Meisn is used as a stimulant, sialagogue and diuretic (Blaskó et 
al., 1988). Apart from medicinal uses, Daphnopsis brasiliensis is used to manufacture 
paper (Adolf and Hecker, 1982) and Daphnopsis ramnosa Griseb fibrous bark is used 
to make rope. D. ramnosa was the first species in this genus on which phytochemical 
studies were conducted and tigliane (2.22), daphnane (2.23), and alpha-alkyldaphnane 
esters were identified (Adolf and Hecker, 1982). Some compounds isolated from species 
in this genus are shown in Figure 2.6 below.  
Tigliane (2.22) Daphnane (2.23)  
Figure 2.6. A few compounds isolated from the genus Daphnopsis. 
2.1.6 Lachnaea L. 
The genus Lachnaea is native to the Cape Floral Region (Beyers and Van Wyk, 1998) 
and was first established by Linnaeus in 1753. New species were later discovered, but 
the taxonomy for the genus was only established in 1840 by Meisner based on Drege’s 
collection (Beyers and van der Walt, 1995). Nineteen species and eight infra-specific 
taxa were discovered in 1915 (Beyers and van der Walt, 1995). However,  there are 34 
species and eight infra-specific taxa known to date (Beyers and Van Wyk, 1998). Most 
species of this genus are found on mountain ranges (Beyers and Van Wyk, 1998). No 
phytochemical results have been reported on this genus. 
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2.1.7 Thymelaea Mill. 
Thymelaea comprises about 30 species of evergreen shrubs (Vincent and Thieret, 
1987). This genus consists of woody and herbaceous species that are native to the 
northern hemisphere of the Old World, especially to the Mediterranean region (Vincent 
and Thieret, 1987). The genus Thymelaea is only represented by one species in North 
America, Thymelaea passerine L (Vincent and Thieret, 1987). Some species in this 
genus are known to have activities against some ailments, for example, Thymelaea 
hirsuta L a medicinal plant that grows in Tunisia (Yahyaoui et al., 2018), is used as a 
decoction in the treatment of diabetes (Djeridane et al., 2006). Apart from being used as 
a decoction in the treatment of diabetes, T. hirsuta has been used in folk medicine as a 
source of antioxidant (Djeridane et al., 2006), and compounds that possess anti-
melanogenic activity (Akrout et al., 2011). The phytochemical investigation revealed that 
the plant is rich in phenolics (2.24) (Figure 2.7) and tannins (Yahyaoui et al., 2018). 
OH
O
HO
OH
Phenolic-caffeic acid (2.24)  
Figure 2.7. Structure of caffeic acid (2.24), a phenolic present in T. hirsuta. 
2.1.8 Phaleria Jack. 
Phaleria comprises about 30 species. However, the predominant species is Phaleria 
macrocarpa (Scheff.) Boerl. because of its anticancer activity (Altaf et al., 2013). P. 
macrocarpa is a medicinal plant that is native to Indonesia and Malaysia. The leaves 
and fruits of this plant have been used for the treatment of several types of cancers since 
the ancient times (Altaf et al., 2013). The extracts of this plant have been evaluated and 
reported to have biological activities like anticancer, antioxidant, antifungal, anti-
inflammatory, antibacterial, antidiabetic and vasorelaxant effects (Hendra et al., 2011). 
Compounds isolated from the various parts of the plant include lignans, flavonoids, gallic 
acid, alkaloids, saponins (1.13), and mangiferin (2.26) (Figure 2.8) (Altaf et al., 2013)  
  
25 | P a g e  
 
 
 
Figure 2.8. Structure of compounds from the genus Phaleria. 
2.1.9 Dais L. 
Dais L. is a small genus in Thymelaeaceae. There are two species, Dais cotinifolia L. 
(SANBI, 2017) (Figure 2.9) and Dais madagascariensis Lam, found in Madagascar 
(Zavada and Lowrey, 1995). D. cotinifolia is the plant of interest in this study. The 
phytochemistry and bioactivity of neither of the two species have been investigated. 
Dais cotinifolia (D. cotinifolia) 
 
Figure 2.9. Dais cotinifolia L.  (photographed by B. Danca). 
Dais cotinifolia L. (kannabas, pompom tree – intozwane emnyama) is a flowering tree 
that belongs to the Thymelaeaceae family. This plant is one of the two species of Dais, 
and is indigenous to South Africa with an isolated population in the eastern highlands of 
Zimbabwe. However it is now widely distributed as a garden tree in a number of 
countries in Africa and Europe . In South Africa the plant is widespread in the eastern 
part of the country, i.e. KwaZulu-Natal, Eastern Cape, Gauteng, Mpumalanga, Limpopo 
and Free State provinces (SANBI, 2017). D. cotinifolia is a small tree that can grow up 
to six meters in height, with flowers that can grow up to three centimeters (Zavada and 
Lowrey, 1995). The flowering times for this plant varies according to the climate 
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conditions of the area. In warm places like Cape Town, the plant flowers in the beginning 
of summer and in cold places, it flowers towards the end of December (SANBI, 2017). 
The plant has a strong bark and as a result, it is used for tying and weaving. The fibrous 
bark are also used for plaiting strong ropes. This plant is not important in traditional 
medicine, but a decoction of the leaves is ingested to treat stomach ache (SANBI, 2017). 
In some countries, the plant is planted for ornamental purposes. The only phytochemical 
report on this is a conference proceeding which mentioned the isolation of lignans from 
the plant extracts, with no indication of the structures of the isolated compounds 
(Crabtree and Belofsky, 2010).  
2.2 Separation of compounds  
Chromatographic techniques are widely used for the analysis of chemical substances 
and natural products, it is used for the separation of complex mixtures and the isolation 
of pure compounds.The mobile phase is the gas or liquid (solvent) that carries the 
components of a sample through the stationary phase, whereas the stationary phase is 
the solid material to which a sample is added. Stationary phases can be kaolin, alumina, 
silica, and activated charcoal.  Substances that are added to a stationary phase move 
according to the rate at which they are adsorbed by both the stationary and mobile 
phases (Skoog et al., 2004). 
2.2.1 Thin-layer chromatography (TLC) 
Thin-layer chromatography (TLC) is a simple, affordable, and fast procedure that 
determines how many components are in a mixture (Meyers and Meyers, 2008). TLC 
can also be used in the identification of unknown compounds by comparing it with a 
known compound using the retention factor (Rf).  To accomplish this, the compound or 
the components of the mixture can be either viewed under ultraviolet (UV) light or 
sprayed by a phytochemical screening reagent that will cause colour change according 
to the class of phytochemicals that are present on the plate. Stains can also be used to 
view the components that are not visible under UV light (Sasidharan et al., 2011). TLC 
can also be used to determine the purity of isolated compounds.  In TLC, the alumina or 
any powdered adsorbent is fixed on the glass, plastic or metal as a stationary phase. 
The mobile phase is then allowed to travel up the stationary phase with the components 
that were spotted just above the solvent (Tesso, 2005).  
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2.2.2 Column chromatography (CC) 
In column chromatography (Figure 2.10), the solutes of a solution are allowed to travel 
down the column, while the separate components are adsorbed by the stationary phase. 
A common stationary phase in natural products is silica gel or alumina. The component 
that is strongly adsorbed by the stationary phase will remain near the top of the column 
while other components travel down the column along with the mobile phase (solvent). 
In column chromatography, there are two different kinds of packing, wet packing and dry 
packing. With wet packing, the silica gel is suspended in a suitable solvent before it is 
introduced onto the column. With dry packing, the silica gel is added dry to the column, 
and then the solvent is added (Tesso, 2005). The solvent system is usually chosen 
according to how the individual components of a solution respond to it on a TLC plate. 
The fractions that are eluted from the column are again monitored by TLC (Tesso, 2005).  
 
Figure 2.10. Column chromatography (photographed by B. Danca). 
2.2.3 High-performance liquid chromatography (HPLC) 
High-performance liquid chromatography (HPLC) is an advanced column 
chromatographic method, whereby the columns are packed with very tiny particles. The 
flow rate is altered to decrease band broadening and also to keep the baseline straight 
(Yamaguchi et al., 1998). The pump is the pressure supplier. HPLC can be performed 
on a normal or a reversed phase column.  With a normal column, polar silica gel and 
non-polar solvents are used, whereas with reversed phase, polar solvents are usually 
used with a non-polar surface of the packing material (Engelhardt, 2012). The HPLC 
system detector determines the solvents that can be used, and also limits compounds 
that can be absorbed (Tesso, 2005).  
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2.2.4 Preparative Centrifugal Thin-layer Chromatography (PCTLC) 
PCTLC (Figure 2.11) is performed on a thin layer of absorbent on a rotor that is covered 
by a teflon lid that is transparent to ultraviolet (UV) light, to allow the detection of UV 
absorbing bands. A motor rotates the rotor at a constant speed by a shaft that passes 
through a hole in the centre of the main vessel. A solution of compounds that is to be 
separated is applied to the absorbent through the inlet and wick. Elution by solvent forms 
concentric bands of separated substances which leave the edge of the rotor together 
with the solvent. A channel collects the eluate and transfers it to the output tube. The 
absorbent layer can be prepared in sizes of 1 mm, 2 mm or 4 mm (Desai et al., 1985).  
 
Figure 2.11. Normal PCTLC (A), PCTLC plate under UV showing concentric bands of 
separated substances (B) (photographed by B. Danca). 
2.3 Structural elucidation 
2.3.1 Nuclear magnetic resonance spectroscopy (NMR) 
NMR is a technique that relies on the ability of unpaired atomic nuclei to spin when it 
interacts with a radio wave at a specific frequency in an external magnetic field. When 
molecules are exposed to a strong magnetic field, the magnetic moment of the nuclei 
align with the magnetic field and when the radio frequency is applied the nuclei gain 
energy (excited state). When the nuclei lose energy (revert to ground state), a radio 
frequency is emitted (Clayden et al., 2001), which is recorded and transformed into a 
NMR spectrum This method helps with the structural elucidation of different chemical 
compounds. One-dimension (1D) NMR (1H NMR) assists with the determination of 
proton environments while 13C NMR determines the carbon atom environments  (Tesso, 
2005). Distortionless Enhancement by Polarization Transfer (DEPT) 135 is used for the 
identification of methylene carbons which appear as negative peaks in the spectrum. 
A B 
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Two-dimension (2D) NMR Correlation Spectroscopy (COSY) relies on 1H,1H 
correlations, whereas Heteronuclear Single Quantum Correlation (HSQC) and 
Heteronuclear Multiple Bonding Correlation (HMBC) spectra give information on the 
1H,13C correlations (Bruice, 2014). 
2.3.2 One-Dimensional NMR 
In 1D pulsed Fourier transform NMR the signal is recorded as a function of a single time 
variable followed by the Fourier transformed to give a spectrum which is a function of a 
single frequency variable, whereas in 2D NMR the signal is noted as a function of two 
time variables followed by a double Fourier transformed to give a spectrum which is a 
function of a double frequency variables (Noda et al., 2000). 
Proton NMR (1H NMR) is used to detect the number of protons in a compound. The 
number of signals designates the different proton environments in a spectrum. 1H is the 
most abundant isotope of hydrogen in nature, 99.985% to be precise. In 1H NMR protons 
couple to show connectivity of the structure (Clayden et al., 2001). A spectrum is divided 
into six regions (Bruice, 2014). The chemical shift range of a spectrum is between 0-12 
parts per million (ppm).  The first region (0-1.5 ppm) is the saturated region followed by 
allylic region (1.5-2.5 ppm), Z= O, N, halogen (2.5-4.5 ppm), vinylic region (4.5-6.5 ppm), 
aromatic region (6.5-8.0 ppm), and a carbonyl region (9.0-12 ppm) (Bruice, 2014). 
The number of signals in a 13C NMR spectrum designates the number of various kinds 
of carbons a compound consists of, just like the number of signals in a 1H NMR spectrum 
tell us the number of various kinds of hydrogens in a compound. The signals in this 
experiment appear as singlets because the 13C NMR are recorded based on the proton 
decoupling and all the 13C-1H coupling are decoupled by irradiation of all the protons. 
This kind of analytical procedure is only carried out through computers that carry out a 
Fourier transform (FT) (Clayden et al., 2001). In 13C NMR, FT is required because 
carbon has a poor sensitivity and this results in obtaining weak signals that are not easily 
differentiated from the background electronic noise and this is because of the the poor 
sensitivity of carbon. 13C FT-NMR has to be rapidly repeated to achieve visible signals 
(Clayden et al., 2001). Visible signals are achieved by adding together many scans that 
are recorded. Hundreds of scans are added together to achieve visible 13C signals. Due 
to the randomness of the electric noise, its sum is close to zero. The separate signals of 
13C are weak, one of the reasons is the isotope of carbon (13C) that produces 13C NMR 
signals. It makes only 1.11% of carbon in nature and also 13C has a very low 
magnetogyric ratio of about one-fourth as compared to that of a proton. The most 
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abundant carbon in nature is 12C, nonetheless, this carbon cannot produce an NMR 
signal because it does not have a nuclear spin. However, 13C NMR spectroscopy has a 
chemical shift of carbon atom range of over 220 ppm, in contrast to 10-12 ppm for 
hydrogens. This enables carbons in different environments to be easily distinguished 
from one another  (Bruice, 2014).  
2.3.3 1D DEPT 13C NMR 
Distortionless Enhancement by Polarization Transfer (DEPT), is a technique that was 
created to differentiate between CH3, CH2, CH and C group (Clayden et al., 2001). This 
technique is now usually used in place of proton-coupled 13C spectra to detect the 
number of hydrogens that are attached to each carbon in a compound (Bruice, 2014). 
2.3.4 Two-dimensional NMR 
This spectroscopy is used to examine complex molecules like proteins and nucleic acids 
because the signals in their spectra overlap. 1H NMR and 13C NMR have one frequency 
axis and one intensity axis, whereas 2D NMR spectra consist of two frequency axes and 
one intensity axis. The common 2D NMR in natural products are COSY, NOESY, HMQC 
and HMBC (Tesso, 2005).  
2.3.5 2D 1H, 1H-COSY (Correlated Spectroscopy) 
Correlated Spectroscopy (COSY) is a 2D NMR spectroscopy that is used in the 
characterization of small molecules but also of larger biomolecules such as proteins. In 
COSY spectroscopy, the spectra show coupling between neighbouring protons in a 2J, 
3J and 4J range (Tesso, 2005).  A 1H NMR spectrum is plotted on both axes (x and y) to 
determine the correlation. In analyzing the spectrum, a diagonal line is drawn through 
the dots that intersect the spectrum (Ernst et al., 1987). Cross peaks that are found on 
the sides of the diagonal line are used to determine proton coupling. The COSY 
spectrum is symmetrical with regards to the diagonal line (Friebolin and Becconsall, 
1993). 
2.3.6 HMBC (Heteronuclear Multiple Bond Correlation) 
The heteronuclear multiple bond correlation (HMBC) experiment is used to determine 
the long-range coupling between hydrogen and carbon that are two or three bonds apart. 
It is used to identify a correlation between 1H and 13C nuclei in different spectra (Clayden 
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et al., 2001). This experiment is sensitive to the extent that it can detect large coupling 
constraints, i.e. 4-10 Hz (Tesso, 2005).  
2.3.7 HSQC (Heteronuclear Single Quantum Correlation) 
The heteronuclear single quantum correlation experiment is used to identify one-bond 
1H and 13C or 15N correlations of two different spectra of a single compound (Tesso, 
2005). In biochemistry, HSQC is used as a correlating experiment between 1H and 15N 
chemical shifts. In chemistry, it is mostly 1H,13C correlations that are important. This 
experiment proved to be useful in elucidating larger molecule (Yuan et al., 2011). 
2.3.8 LCMS (Liquid Chromatography-Mass Spectrometry) 
Liquid chromatography-mass spectrometry (LC-MS) experiments are a combination of 
chromatography and mass spectrometry. As all different chromatography methods, LC 
has a stationary and a mobile phase. The stationary phase is a solid and a mobile phase 
is a gas. Mass spectrometry is used for the mass measurement. LCMS as a combined 
method deals with separation and measurement. In this technique, a sample is injected 
onto a column, eluted with a selected solvent system (Lindsey et al., 2001). The mass 
of an LC eluent is measured by a MS detector, the commonly used MS detector is a 
triple quadrupole MS (QQQ). In a MS QQQ a high voltage is applied into an LC eluent 
which creates a spray of ionized molecules, the ionized molecule is transferred to the 
first quadrupole where they are separated and selected according to specific ions 
(Taylor, 2005). In the second quadrupole the specific ion is fragmented into product ions, 
and the product ions are transferred to the third quadrupole. In the third quadrupole, a 
product ion is isolated and sent to a detector for measurement. However, in this study, 
the MS used was a single quadrupole which only deals with separation and selection of 
a specific ion. The results are displayed as molecular ion adducts (Niessen, 2006).  
2.3.9 Time-Of-Flight Mass Spectrometry 
Mass spectrometry (MS) is an analytical technique that helps with structural elucidation. 
This technique measure mass (m) to charge (z) ratio (m/z) of the ions in an analyte or 
sample (Breitkopf et al., 2017). The ratios that are obtained from the results provide 
atomic signatures for the different components of the sample. Usually z = 1, therefore, 
the ratio is the mass of the ion. MS gives a mass as an integer (Breitkopf et al., 2017). 
The disadvantage of this technique is that a molecular mass does not give concrete 
evidence of the exact mass of a compound. High-resolution mass spectrometry (HRMS), 
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is used to amend that disadvantage by means of determination of the exact mass of a 
fragment to a 0.0001 precision by separating the analyte into fragments prior to analysis. 
This technique gives the molecular weight in five decimal places, and this eliminates 
99% of the error, hence making it easy to differentiate between the compounds with a 
similar molecular mass to the nearest integer (Clayden et al., 2001). Time-of-flight is an 
HRMS technique that uses time measurement to determine m/z of an ion. This technique 
is used for both qualitative and quantitative analyses. Accurate results can be obtained 
from the spectral data of this instrument. This technique provides an accurate mass and 
isotopic reliability (Issaq et al., 2002).  
2.3.10 Ultraviolet (UV) spectroscopy 
The ultraviolet (UV) spectroscopy gives details of the organic compounds with 
conjugated double bonds. The part of the molecule that absorbs UV light is called a 
chromophore.  UV light consists of relevant energy that causes an electronic transition 
in a molecule. In other words, it causes an electron to move from one molecular orbital 
to a molecular orbital with higher energy (excited state) (Förster, 2004). The molecules 
that absorb UV light have a UV spectrum that ranges between 180-400 nm, in contrast 
to visible light which ranges between 400-780 nm. A UV spectrum consists of broad 
absorption bands due to electronic state that has vibration sublevels. Therefore, the 
electronic transitions occur within these various sublevels (Bruice, 2014).   
2.4 Conclusion 
To conclude, though a number of plants have been studied and found to have bioactive 
compounds, there is still a need to explore the phytochemistry of many other South 
African indigenous species.  No literature is available on the phytochemistry of the genus 
Dais. Exploring the phytochemistry of this genus could possible results in obtaining new 
bioactive compounds with interesting properties. 
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Chapter 3: Results and Discussion 
3.1 Introduction 
As discussed in Chapter 2, many bioactive compounds have been isolated from plants 
of the Thymelaeaceae family. The compounds are active against several diseases that 
claim lives in South Africa, i.e. cancer, hypertension, malaria, diabetes and HIV. This 
plant family is well represented in most provinces in South Africa. The focus of this thesis 
was to investigate the phytochemistry of a Thymelaeaceae species that has not been 
studied previously and Dais cotinifolia was selected. 
D. cotinifolia was collected from the University of Kwazulu-Natal Pietermaritzburg 
campus (UKZN-PMB) Botanical Garden. The different parts of the plant, i.e. leaves, 
branches, roots and root bark, were dried and extracted using different solvent systems. 
The structures of the compounds were elucidated by interpretation of their 1H and 13C 
NMR, LC-MS, TOF-MS and UV/Vis experimental data and by comparison with literature 
data. The antioxidant activity of the various crude extracts was determined.  
3.1.1. Isolation and structural elucidation of kobusin (3.1) 
The crude DCM extract of the leaves was fractionated by VLC. TLC was used to monitor 
the fractions and one fraction (fraction C) was taken for further fractionation by VLC and 
preparative centrifugal thin-layer chromatography. A single compound (3.1) was isolated 
and the purity of the compound was assessed by HPLC (Figure 3.1).  
 
Figure 3.1. HPLC chromatogram of kobusin (3.1). 
The structural elucidation of 3.1 was based on NMR, MS and UV analysis. In the low-
resolution ESI-(+) mass spectrum of 3.1, a pseudo-molecular ion was observed at m/z 
34 | P a g e  
 
393.1 [M+Na]+, which corresponds to a molecular formula of C21H22O6 (calculated for 
C21H22O6Na, 393.4). 
The NMR data of compound 3.1 are collated in Table 3.1. The proton NMR analysis was 
based on the 1H NMR (Figure 3.2) and COSY NMR (Figure 3.3) spectra.  There was 
evidence of six aromatic protons that were allocated to two aromatic rings. A careful 
analysis of the splitting patterns of the aromatic proton signals indicated that there were 
two 1,3,4-trisubstituted phenyl rings (arbitrarily designated as ring A and ring B).  In ring 
A, a proton signal was observed at δH 6.84 (1H, d, J = 8.3 Hz, H-5) and this proton was 
ortho-coupled to the proton resonating at δH 6.87 (1H, dd, J = 1.8 Hz; 9.9 Hz, H-6). The 
proton resonating at δH 6.87 also has a meta-coupling to the proton resonating at δH 
6.90 (1H, d, J = 1.7 Hz, H-2). On the other aromatic ring (ring B), the proton resonating 
at δH 6.85 (1H, d, J = 1.7 Hz, H-2') was meta-coupled to a proton resonating at δH 6.81 
(1H, dd, J = 1.3 Hz; 8.2 Hz, H-6'). The proton resonating at δH 6.81  was ortho-coupled 
to the proton resonating at δH 6.78 (1H, d, J = 8.0 Hz, H-5') and meta-coupled to the 
proton resonating at δH 6.85.  
Figure 3.2. 1H NMR spectrum of kobusin (3.1) in CDCl3 at 400 MHz. 
At δH 5.95, a two-proton singlet resonance was observed and the chemical shift indicated 
that these protons were attached to a carbon atom bonded to two oxygen atoms. These 
protons were assigned as a -OCH2O- (methylenedioxy) group. More upfield, there was 
an indication of two closely-related sets of protons resonating at δH 4.75 (d, J 5.5 Hz) 
and 4.73 (d, J 5.4 Hz) ppm, a two-proton multiplet at δH 4.26 ppm, a 2-proton multiplet 
at δH 3.87 ppm and a two-proton multiplet resonating at δH 3.12 ppm. In the COSY 
spectrum (Figure 3.3), a correlation was observed between the proton resonance at δH 
4.74 and the resonance at δH 3.12 ppm. The latter resonance also showed a correlation 
with both the resonances at δH 4.26 ppm and δH 3.87. These two resonances also 
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showed a correlation with each other. The remaining two signals in the 1H NMR 
spectrum were two three-proton singlets resonating at δH 3.90 and δH 3.87, consistent 
with two methoxy groups attached to aromatic rings. 
 
Figure 3.3. COSY NMR spectrum of kobusin (3.1) in CDCl3. 
In the 13C NMR spectrum (Figure 3.4), there were 21 signals indicating that there were 
21 carbons in different chemical environments. A DEPT spectrum (Figure 3.5) was used 
to differentiate between methyl, methylene, methine and quaternary carbon atom 
resonances. The HSQC spectrum (Figure 3.6) enabled us to establish one-bond 
correlations between proton and carbon atoms, whereas the HMBC spectrum (Figure 
3.7) allowed us to connect different fragments. 
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Figure 3.4. 13C NMR spectrum of kobusin (3.1) in CDCl3 at 100 MHz. 
 
Figure 3.5. DEPT 135 NMR spectrum of kobusin (3.1) in CDCl3 at 100 MHz. 
In the aromatic region, six quaternary carbons resonated between δC 133 and 149 ppm. 
Among the six quaternary carbons, four were more downfield, indicating that they were 
directly bonded to oxygen atoms. These four resonances were at δC 147.3, 148.2, 148.9 
and 149.5 ppm, while the other two quaternary carbons resonated at 133.8 and 135.3 
ppm.  Six additional aromatic carbon signals ranging from δC 106.7 to 119.6 ppm were 
identified as methine carbons. In the HSQC spectrum, it was observed that the three 
proton resonances on aromatic ring A, δH 6.84 (s, J = 8.3 Hz, H-5), δH 6.87 (dd, J = 1.8 
Hz; 9.9 Hz, H-6) and δH 6.90 (d, J = 1.7 Hz, H-2), correlated to the carbon resonances 
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at δC 109.5, 118.5 and 111.4, respectively. The three B-ring proton resonances at δH 
6.85 (d, J = 1.7 Hz, H-2'), δH 6.81 (dd, J = 1.3 Hz; 8.2 Hz, H-6'), and δH 6.78 (d, J = 8.0 
Hz, H-5') correlated to the carbon resonances at δC 106.7, 119.6, and 108.4, 
respectively. 
 
Figure 3.6. HSQC NMR spectrum of kobusin (3.1) in CDCl3. 
In the HMBC spectrum (Figure 3.7), a correlation between the proton resonance at δH 
6.84 (J = 8.3 Hz, H-5, ring A) and the carbon resonance at δC 149.5, and the proton 
resonance at δH 6.90 (H-2, ring A) and the carbon resonance at δC 149.5, were 
observed. Therefore, the signals at δC 149.5 and δC 149.5 were assigned to C-3 and C-
4, respectively, of ring A. In the HMBC spectrum, a correlation between the signals at 
δC 149.5 and δC 148.9 and the methoxy proton resonances at δH 3.90 and δH 3.87, 
respectively, were observed. The methoxy proton resonances at δH 3.87 and 3.90 
correlated to the carbon resonances at δC 56.2 and 56.1, respectively, in the HSQC 
spectrum (Figure 3.8).  The correlations discussed above enabled us to assign a part 
structure to ring A (Figure 3.8). 
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Figure 3.7. HMBC NMR spectrum of kobusin (3.1) in CDCl3. 
A methylene carbon resonating at δC 101.3 was observed in the DEPT spectrum (Figure 
3.5) and in the HSQC spectrum (Figure 3.6) and this carbon resonance correlated to the 
proton resonance at δH 5.95, confirming the presence of a –OCH2O- fragment. In the 
HMBC spectrum (Figure 3.7), the methylene proton resonance (δH 5.95) correlated to 
the two B-ring carbon resonances at δC 148.2 and 147.3. These two resonances also 
correlated to proton resonances at δH 6.81 (H-5') and δH 6.85 (H-2'), respectively, and 
was assigned to C-3' and C-4', respectively. These correlations allowed us to construct 
ring B as indicated in Figure 3.8. 
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Figure 3.8. Part-structures proposed for ring A and ring B of 3.1. 
The remaining signals in the 13C NMR spectrum consisted of three pairs of resonances 
at δC 86.1/86.0 (oxymethine), δC 72.0/71.9 (oxymethylene) and δC 54.6/54.4 (methine 
carbon). These carbons correlated to the proton resonances at δH 4.75/4.73 ppm, the 
two-proton multiplet at δH 4.26 ppm and the two-proton multiplet at δH 3.87 ppm, and the 
two-proton multiplet resonating at δH 3.12 ppm, respectively. This observation allowed 
us to propose the presence of two -OCH2-CH-CHO- fragments in compound 3.1. By 
39 | P a g e  
 
combining these two fragments with ring A and ring B, a furofuran lignan structure was 
proposed for 3.1, with the signals at δH 4.75/4.73 ppm assigned to H-7/7', δH 3.12 ppm 
to H-8/8', and signals at δH 4.26 ppm and δH 3.87 ppm to the two diastereotopic protons 
at C-9/9'. 
There are 4 stereocentres in the proposed furofuran lignan; therefore, there are eight 
possible diastereomers. Geometric constraints restrict the ring junction between the two 
five-membered rings as cis and only four possible diastereomers remain, the 7-H/8-H 
trans, 7'-H,8'-H trans isomer (A), the 7-H/8-H trans, 7'-H,8'-H cis isomer (B), the 7-H/8-
H cis, 7'-H,8'-H trans isomer (C), and the 7-H/8-H cis, 7'-H,8'-H cis isomer (D) (Figure 
3.9). 
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Figure 3.9. Possible diasteromers for furofuran lignans. 
The determination of the relative configuration of the furofuran lignans is not always easy 
to determine by NMR due to conformational changes that can occur with different 
substituents on C-7 and C-7'. Takahashi and Nakagawa (1966) reported that a small 
coupling constant (J ≈ 4 Hz) between 7-H/8-H or 7′-H/8′-H corresponds to a trans 
configuration and a large coupling constant (J ≈ 7 Hz) corresponds to a cis configuration. 
Kamikado et al. (1975) reported that for the symmetric diastereomer A (Figure 3.9), the 
chemicals shift of H-7, 8 and 9 are almost the same as those of H-7', 8' and 9', whereas 
for the asymmetric diastereomer C, substantial chemical shift differences for these 
protons were observed. By considering the NMR data of a number of furofuran lignans, 
it was proposed that the relative configuration of these compounds could be derived by 
considering the chemical shift differences between the two diastereotopic protons on C-
9 and C-9' (Xu et al., 2018). These authors proposed that for type A (Figure 3.9), ΔδH‑9 
and ΔδH‑9′ = 0.30−0.40, for type B and type C ΔδH‑9 = 0.25−0.36, ΔδH‑9′ > 0.50, and 
for type D ΔδH‑9 and ΔδH‑9′ < 0.20. 
Considering the discussion above, 3.1 was identified as a class A lignan (Figure 3.9). 
The small differences in chemical shifts between H-7 and H-7′, H-8 and H-8′, and H-9 
and H-9′, indicated that the furofuran moiety is symmetrical and that class B and class 
C could be eliminated.  The coupling constant between H-7 and H-8 and also between 
H-7' and H-8' in 3.1 are both J ~ 5.5 Hz, which is in agreement with a trans relationship 
between the protons.  Finally, the chemical shift difference between the two 
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diastereotopic C-9 protons is δH = 4.26 – 3.87 = 0.39, which is characteristic of a 7-H/8-
H trans, 7'-H,8'-H trans isomer (Xu et al., 2018). 
Based on the NMR data discussed above, the structure of the isolated compound 3.1 
was identified as kobusin (Figure 3.10), a lignan that was first reported by Kamikado et 
al. (1975), who isolated the compound from Magnolia kobus DC. The NMR data of 
kobusin (3.1) is in agreement with the published data by Kamikado et al., 1975. 
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Figure 3.10. Structure of kobusin (3.1). 
The UV/Vis spectrum of compound 3.1 showed two absorption maxima at λmax = 230 nm 
and λmax = 285 nm (Figure 3.11). This spectrum is in agreement with the chromophore 
of the proposed structure, i.e. two benzene rings. 
 
 
 
 
 
 
 
Figure 3.11. The UV/Vis spectrum of kobusin (3.1). 
As stated already above, the furofuran lignan kobusin (3.1) was first isolated from the 
methanol crude extract of the leaves and seeds of Magnolia kobus DC. and this lignan 
was found to be a growth inhibitor of silkworm larvae (Iida et al., 1982, Kamikado et al., 
1975). The same lignan was also isolated from the plant Melicope hayesii T.G.Hartley 
in 1999 (Latip et al., 1999). 
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Table 3.1. 1H (400 MHz) and 13C (100 MHz) NMR data of kobusin (3.1) in CDCl3. 
Position δC (ppm) δH (ppm) δH (ppm) 
(Kamikado et al., 
1975) 
δC (Latip et al., 
1999) 
1 
1’ 
133.8 
135.3 
-  135.7 
2 
2’  
109.5 
106.7 
6.90 (1H, d, J = 1.7 
Hz) 
6.85 (1H, d, J = 1.7 
Hz) 
 
* 106.4 
3 
3’ 
148.9 
147.3 
-  147.8 
4 
4’ 
149.5 
148.2 
-  148.8 
5 
5’ 
111.4 
108.4 
6.84 (1H, d, J = 8.3 
Hz) 
6.78 (1H, d, J = 8.0 
Hz) 
* 109.3 
6 
6’ 
118.5 
119.6 
6.87(1H, dd, J = 1.8 
Hz; 9.9 Hz) 
6.81 (1H, dd, J = 1.3 
Hz; 8.2 Hz) 
* 119.3 
7 
7’ 
86.0 
86.1 
4.74 (2H, d, J = 5.5 
Hz) 
4.75 (2H, d, J = 4) 86.6 
8 
8’ 
54.4 
54.6 
3.08 (2H, m)  54.9 
9 
9’ 
71.9 
72.0 
4.26 (1H, m) 
3.87 (1H, m) 
4.16 – 4.40 (2H, m) 71.9 
O-Me 56.2 3.87 (3H, s) 3.87 (3H, s) 56.1 
O-Me 56.1 3.90 (3H, s) 3.90 (3H, s)  
O-CH2-O 101.3 5.96 (2H, s) 5.95 (2H, s) 101.2 
*Given as δH 6.8-7.8 (6H, Ar-H) by Kamikado et al. (1975). 
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3.1.2 Isolation and structural elucidation of eudesmin (3.2) 
The crude MeOH extract of the leaves was fractionated by VLC. TLC was used to 
monitor the fractions and fraction C was further fractionated by preparative centrifugal 
thin-layer chromatography. The purity of a single compound that was isolated was 
assessed by HPLC (Figure 3.12). 
 
Figure 3.12. A HPLC chromatogram of eudesmin (3.2). 
The structural elucidation of 3.2 was performed on the basis of NMR, MS and UV 
analysis. The low-resolution ESI-(+)-mass spectrum of 3.2, a pseudo-molecular ion was 
observed at m/z 409.3 [M+Na]+, which corresponds to a molecular formula of C22H26O6 
(calculated for C22H26O6Na, 409.4). 
The NMR spectroscopic data of compound 3.2 are summarised in Table 3.2. Both the 
1H and 13C NMR spectra of 3.2 were much simpler than those of 3.1. In the 1H NMR 
spectrum (Figure 3.13) nine different signals, including two methoxy resonances were 
observed, whereas in the 13C NMR spectrum (Figure 3.15), eleven carbon resonances 
could be observed. Taking the molecular mass into account, it was clear that 3.2 was a 
symmetrical molecule.  
The proton environments of the proposed structure were determined using 1H NMR 
(Figure 3.13) and COSY NMR (Figure 3.14) spectra. Since 3.2 was identified as a 
symmetrical molecule, only one half of the molecule will be discussed. There was an 
indication of 3 aromatic protons that were attributed to an aromatic ring. The splitting 
patterns indicated that this was a 1,3,4-trisubstituted phenyl ring. A proton that resonated 
at δH 6.91 (d, J = 2.3 Hz) was observed, and this proton was meta-coupled to the proton 
resonating at δH 6.87. A proton resonating at δH 6.85 (d, J = 2.35 Hz) was observed, and 
this proton was ortho-coupled to the proton resonating at δH 6.87 (2H, d, J = 2.3 Hz; 7.0 
Hz).   
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Figure 3.13. 1H NMR spectrum of eudesmin (3.2) in CDCl3 at 400 MHz. 
At δH 4.76 a one-proton doublet resonance was observed, and the chemical shift 
indicated that this proton was attached to a carbon bonded to an oxygen. The proton 
was assigned as a -OCHPh- (oxymethine) group. A proton resonating at δH 4.29 was 
split by a proton resonating at δH 3.89. This suggested the presence of a methylene 
group and the chemical shift indicated that the protons were attached to a carbon 
bonded to an oxygen. There were two singlets resonating at δH 3.89 and δH 3.87, 
consistent with methoxy groups attached to an aromatic ring. A one-proton multiplet 
resonance at δH 3.12 was observed and this proton was assigned as a -CH- (methine) 
group.   
 
Figure 3.14.  COSY NMR spectrum of eudesmin (3.2) in CDCl3. 
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The 13C NMR spectrum (Figure 3.15) showed signals equivalent to 11 carbons and this 
was due to the plane of symmetry in the proposed structure. A DEPT spectrum (Figure 
3.16) was used to differentiate between methyl, methylene, methine and quaternary 
carbon atom resonances. The HSQC spectrum (Figure 3.17) enabled us to establish 
one-bond correlations between proton and carbon atoms, whereas the HMBC spectrum 
(Figure 3.18) allowed us to connect different fragments. 
There were six aromatic carbon resonances between δC 109.5-149.5. Three of these 
carbon resonances were attributed to quaternary carbons. The chemical shifts of the 
quaternary carbon resonances at δC 148.9 and 149.5 indicated that they were directly 
bonded to oxygen and the carbon at δC 133.8 was C-C bonded. In the DEPT NMR  and 
HSQC NMR, three other aromatic carbons ranging between δC 109.5-118.5 ppm were 
identified as methine carbon signals. The rest of the signals were observed at δC 86.0 
(oxymethine), 71.9 (oxymethylene) and 54.4 (methine). The last two signals at δC 56.1 
and 56.2 were assigned as two methoxy carbons.   
 
Figure 3.15. 13C NMR spectrum of eudesmin (3.2) in CDCl3 at 100 MHz. 
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Figure 3.16.  DEPT 135 NMR spectrum of eudesmin (3.2) in CDCl3 at 100 MHz. 
 
Figure 3.17.  HSQC NMR spectrum of eudesmin (3.2) in CDCl3. 
The HSQC spectrum (Fig 3.15) confirmed that the proton resonating at δH 4.26 was 
attached to the same carbon as the proton at 3.89, confirming that this was an 
oxymethylene group.  
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Figure 3.18.  HMBC NMR spectrum of eudesmin (3.2) in CDCl3. 
The HMBC spectrum (Figure 3.18) showed a 3J correlation between δC 148.7 and the 
methoxy proton protons. A 3J connectivity was between a proton resonating at δH 4.76 
and carbons resonating at δC 85.8, δC 133.6 and δC 109.3. This confirms that in the 
proposed structure, a furofuran ring system is connected to a benzene ring. This was 
further confirmed by the 2J correlation of a proton resonating at δH 4.76 and carbons 
resonating at δC 85.8 and δC 133.6. A 2J connectivity was observed between the carbon 
resonating at δC 54.7 and the proton resonating at δH 4.76 and also the proton resonating 
at δH 4.27. Similar to compound 3.1, compound 3.2 was a lignan with signals at δH 4.73 
ppm assigned to H-7/7', δH 3.12 to H-8/8', and signals at δH 4.25 and 3.85 attributed to 
the two diastereotopic protons at H-9/9’.  
The structure of the isolated compound was assigned as eudesmin (3.2) (Figure 3.19). 
The isolation and NMR structural elucidation of eudesmin were first reported in 1975 
when it was isolated from Magnolia kobus DC (Kamikado et al., 1975). The isolation of 
this compound from D. cotinifolia has not been reported previously. The NMR data was 
consistent with data reported previously (Yang et al., 2006). Kobusin (3.1) and eudesmin 
(3.2) have the same relative stereochemistry (Yang et al., 2006). 
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Figure 3.19. Structure of eudesmin (3.2). 
The UV/Vis spectrum of compound 3.2 showed two absorption wavelengths (λmax = 230 
nm and λmax = 280 nm) (Figure 3.20). The chromophore of the proposed structure was 
the benzene ring. 
 
 
 
 
 
 
Figure 3.20. The UV/Vis spectrum of eudesmin (3.2). 
Similar to kobusin (3.1), eudesmin (3.2) was first isolated from the methanol crude 
extract of  Magnolia kobus as a growth inhibitor of silkworm larvae. They were also both 
isolated from Melicope hayesii (Latip et al., 1999). The furofuran lignans are known to 
possess a number of biological activities, including anti-inflammatory, cytotoxic and 
antioxidant activity (Xu et al., 2018). The antioxidant free radical scavenging activity 
enables these lignans to prevent cancer. There have been a number of studies that have 
been conducted to investigate the anticancer activity of lignans, and the literature states 
that lignans have a protective effect against cancer, hormone-related cancers in 
particular, i.e. breast cancer (Thompson, 1998).  
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Table 3.2. 1H (400 MHz) and 13C (100 MHz) NMR data of eudesmin (3.2) in CDCl3. 
H and C positions δC δH δH (Yang et al., 2006) δC (Yang et al., 2006) 
1/1’ 133.6 -  134.8 
2/2’  109.3 6.91 (2H, d, J = 
1.6 Hz) 
7.02 (2H, d, J = 1.0 
Hz) 
110.5 
3/3’ 148.7 -  149.9 
4/4’ 149.3 -  149.2 
5/5’ 111.2 6.85 (2H, d, J = 
8.2 Hz) 
6.92 (2H, d, J = 8.5 
Hz) 
112.1 
6/6’ 118.3 6.87 (2H, dd, J = 
8.2, 1.6 Hz) 
 
6.94 (2H, dd, J = 2.0, 
6.0 Hz) 
118.5 
7/7’ 85.8 4.76 (2H, d, J = 
4.2 Hz) 
4.73 (2H, d, J = 4.5 
Hz) 
85.9 
8/8’ 54.2 3.12 (2H, m) 3.10-3.14 (2H, m, H-
8, H-8') 
54.6 
9/9’a 
9/9’b 
71.7 4.27 (1H, dd, J = 
9.0, 6.8 Hz) 
3.89 (1H, m)  
4.25 (2H, dd, J = 5.5, 
8.0 Hz) 
3.85 (2H, dd, J = 4.0, 
11.0 Hz) 
71.7 
O-Me 56.0 3.87 (3H, s) 
3.89 (3H, s) 
3.82 (6H, s, 4- and 4') 
3.84 (6H, s, 3- and 3') 
55.6 
 
3.1.3 Isolation and structural elucidation of catechin (3.3) 
The crude MeOH extract of the root bark was fractionated by VLC. TLC was used to 
monitor the fractions. Fraction E was further purified by column chromatography and 
preparative TLC.  
The structural elucidation of 3.3 was based on NMR, MS and LC-MS analysis. In the 
low-resolution ESI-(+)-mass spectrum of 3.3 obtained from a LC-MS run (Figure 3.21), 
a molecular ion was observed at m/z 291 [M+Na]+, which corresponds to a molecular 
formula of C15H13O6 (calculated for C15H13O6Na, 291).  
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Figure 3.21. The LC-MS spectrum of catechin (3.3). 
The NMR data of 3.3 are collated in Table 3.3. The proton NMR analysis was based on 
1H NMR (Figure 3.22) and COSY NMR (Figure 3.23) spectra. There was evidence of 5 
aromatic protons that were allocated to two aromatic rings. A careful analysis of the 
splitting patterns of the aromatic protons revealed that one ring was a 1,2,3,5-
tetrasubstituted phenyl ring (benzopyran ring system) and the second one was a 1,3,4-
trisubstituted phenyl ring. A proton resonance was observed at δH 5.93 (1H, d, J = 2.3 
Hz). This proton was meta-coupled to the proton resonating at δH 5.86 (1H, d, J = 2.3 
Hz). A proton resonance was observed at δH 6.72 (1H, dd, 1.9, 8.2 Hz) and this proton 
was meta-coupled to the proton resonating at δH 6.84 (1H, d, J = 1.9 Hz) and ortho-
coupled to the proton resonating at δH 6.77 (1H, d, J = 8.1 Hz). A one-proton signal 
resonating at δH 4.57 was observed and the chemical shift indicated that the proton was 
attached to both an oxygen and a phenyl group and was assigned as a -CH- (methine) 
group. A one-proton multiplet resonating at δH 3.98 was observed, the chemical shift 
indicated that the proton was attached to a carbon bonded to a hydroxy group and was 
assigned as a -HCOH- (hydroxymethylene). At δH 2.85 a one-proton doublet of doublets 
(dd) was observed and this proton was split by a one-proton signal resonating at δH 2.51. 
The proton was assigned as a -CH2- (methylene) group. 
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Figure 3.22. 1H NMR spectrum catechin (3.3) in CD3OD at 400 MHz. 
A COSY correlation confirmed that the protons resonating at δH 2.85 and δH 2.51 were 
attached to the same carbon and that the multiplicity of these protons was a dd. A proton 
resonating at δH 4.57 showed a correlation to a proton resonating at δH 3.98, and was 
assigned as a doublet. A proton resonation at δH 3.98 had a correlation with the proton 
resonating at δH 2.85 and δH 2.51 and was assigned as a multiplet. 
 
 
Figure 3.23.  COSY NMR spectrum of catechin (3.3). 
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In the 13C NMR spectrum (Figure 3.24), fifteen carbon signals were observed. There 
were twelve aromatic carbons resonating at δC 95.7-158.0 ppm and seven of these were 
quaternary carbons with five carbons directly bonded to oxygen. The five C-O carbons 
resonated at δC 158.0, 157.7, 157.0, 146.4 and 146.3 ppm. The other two quaternary 
carbons resonated at δC 132.4 and 101.0 ppm. In the DEPT NMR (Figure 3.25) and 
HSQC NMR (Figure 3.26) spectra, the other aromatic carbons were identified as 
methine carbons. The rest of the signals were observed at δC 83.0 (methine), 68.9 
(hydroxymethylene) and 28.6 (methylene). 
 
Figure 3.24. 13C NMR spectrum of catechin (3.3) in CD3OD at 100 MHz. 
 
Figure 3.25.  DEPT 135 NMR spectrum of catechin (3.3) in CD3OD at 100 MHz. 
52 | P a g e  
 
 
Figure 3.26.  HSQC NMR spectrum of catechin (3.3) in MeOH. 
The HMBC NMR spectrum (Figure 3.27) and Figure 3.29 were used to confirm 
connectivities between the atoms in the proposed structure. A 2J correlation was 
observed between the carbon resonating at δC 158.0 and a proton resonating at δH 5.93. 
Another 2J connectivity was observed between proton resonating at δH 5.86 and a 
carbon at δC 95.7. There was a 2J correlation between a carbon resonating at δC 132.4 
and a proton at δH 4.57, confirming the connectivity between a benzene ring and a pyran 
ring system. 3J correlations were observed between a carbon resonating at δC 101.0 and 
proton resonances at δH 3.98, 2.85 and 2.51. These correlations confirmed the presence 
of a benzopyran ring system and were supported by the correlation of carbons 
resonating at δC 101.0 and 157.7 and protons at δH 5.93 and 5.86. The NMR data 
suggested that the isolated compound was catechin (3.3) (Figure 3.28). The long-range 
1H,13C-correlations derived from the HMBC spectrum (Figure 3.27) for 3.3 are indicated 
in Figure 3.29. 
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Figure 3.27.  HMBC NMR spectrum of catechin (3.3) in CD3OD. 
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Figure 3.28. Structure of catechin (3.3). 
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Figure 3.29. HMBC correlations observed for catechin (3.3). 
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Figure 3.30. HPLC UV spectrum of catechin (3.3). 
The UV spectrum of compound (3.3), obtained from the diode-array detector of the 
HPLC, showed a maxima absorption at λmax = 280 nm (Figure 3.30). This spectrum is in 
agreement with the chromophore of the proposed structure, which is a benzene ring. 
Table 3.3. 1H (400 MHz) and 13C NMR (100 MHz) data of catechin (3.3) in CD3OD. 
Carbon (C) and 
Proton (H) 
Positions 
δH (ppm) δC (ppm) DEPT-135 
 
1’ - 132.4  
2’ 6.72 (1H, dd, 1.92, 8.16 Hz) 120.2 CH 
3’ 6.77 (1H, d, J = 8.12 Hz) 116.3 CH 
4’ - 146.3 - 
5’ - 146.4 - 
6’ 6.84 (1H, d, J = 1.90 Hz) 115.4 CH 
2 4.57 (1H, d, J = 7.48 Hz) 83.0 CH 
3 3.98 (1H, m, Hz) 68.9 CH 
4α 
4β 
2.85 (1H, dd, J = 5.44, 10.72 
Hz) 
2.51 (1H, dd, J = 8.12, 8.00 
Hz) 
28.6 CH2 
4a - 101.0 - 
5 - 157.0 - 
6 5.86 (1H, d, J = 2.32 Hz) 95.7 CH 
7 - 158.0 - 
8 5.93 (1H, d, J = 2.28 Hz) 96.5 CH 
8a - 157.7 - 
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The most common type of catechins is tea catechin, which is a major constituent of fresh 
tea (Okushio et al., 1996). Catechins that are abundant in green tea are epicatechin, 
epicatechin gallate, epigallocatechin and epigallocatechin gallate (Okushio et al., 1996). 
The configurations at C-2 and C-3 are used to describe the compounds.If the relative 
configuration is trans, the compound is called catechin and if it a cis, the compound is 
called epicatechin. Catechin, like most flavonoids, possesses antioxidant activity, 
therefore, preventing the effects of cancer.   
3.1.4 Structural elucidation of 3.4 
The crude DCM extract of the leaves was fractionated by VLC. HPLC analysis indicated 
the presence of two compounds in fraction B of the VLC. The compounds that were 
labelled by the chromatogram (Figure 3.31) were then isolated by semipreparative 
HPLC. The mass of the compound correlating with peak A was very small and 
spectroscopic data could not be obtained. Compound 3.4 was obtained from peak B. 
Further HPLC analysis (Figure 3.32) confirmed the purity of 3.4. 
 
Figure 3.31. HPLC chromatogram showing the separation of a fraction of the crude 
DCM extracts of the leaves. 
 
Figure 3.32. HPLC chromatogram of 3.4. 
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The structural determination of 3.4 was based on NMR, MS and UV analysis. In the 
high-resolution ESI-(+)-mass spectrum of 3.4 (Figure 3.33), a pseudo-molecular ion was 
observed at m/z 337.1403 [M+Na]+, corresponding to a molecular formula of C19H22O4 
(calculated for C19H22O4Na, 337.1416). 
 
Figure 3.33. The ESI-(+)-TOF-MS spectrum of 3.4. 
The NMR spectroscopic data of compound 3.4 are summarised in Table 3.4. The 1H 
NMR spectrum Figure 3.34 suggested that there were eight aromatic protons distributed 
around two aromatic rings and resonating δH 6.70 – 7.84. Two two-proton resonances 
at δH 7.84 (2H, d, J = 8.9 Hz) and 6.94 (2H, d, J = 8.9 Hz) were characteristic of a 1,4-
disubstituted phenyl ring and a correlation between them could be observed in the COSY 
spectrum (Figure 3.35). The triplet resonance at δH 7.16 (1H, t, J = 7.8 Hz), two broad 
doublets at δH 6.70 (1H, d, J = 7.2 Hz) and 6.73 (1H, d, J = 8.5 Hz) and a broad singlet 
at δH 6.94 in the 1H NMR spectrum suggest the presence of a second disubstituted 
benzene ring. The triplet signal at δH 7.16 (1H, t, J = 7.8 Hz) indicated the presence of a 
proton adjacent to two other ortho-protons and thus the presence of a 1,3-disubstituted 
phenyl ring.  
A signal for a methine proton was observed at δH 5.01 (1H, dd, J = 2.8, 7.5 Hz). The 
chemical shift of this proton suggested that it is not only on a carbon that contains an 
oxygen substituent, but that there is also another electron-withdrawing group attached 
to the carbon. In the COSY spectrum (Figure 3.35), a correlation with a signal at δH 1.57 
(overlapping with water peak), which was assigned to an aliphatic methylene. In the 
aliphatic region, a total of six protons were observed as complex multiplets at δH 2.64 
(1H, m), 2.57 (1H, m), 1.87 (2H, m), 1.75 (1H, m), 1.57 (1H, m). A COSY correlation was 
observed between the protons resonating at δH 2.61 and 2.57 and this observation 
suggested that these protons were attached to one carbon. The COSY correlation also 
suggested that the proton resonances at δH 1.87 and 1.57 were attached to the same 
carbon and lastly the proton resonances at δH 1.87 and 1.75 ppm were also assigned to 
two methylene protons. The aliphatic signals were assigned to three adjacent methylene 
groups. Therefore, the following fragment could be constructed: -CHOH-CH2CH2CH2-. 
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/ 
Figure 3.34. 1H NMR for compound 3.4 in CDCl3 at 500 MHZ. 
 
Figure 3.35.  COSY NMR spectrum of compound 3.4. 
The remaining two signals were observed as two three-proton singlets resonating at δH 
3.89 and δH 3.77, consistent with methoxy groups attached to an aromatic ring. 
Only a small amount of 3.4 could be isolated and not enough material was available for 
a 13C NMR spectrum. However, by using the 13C projections of the HSQC (Figure 3.36) 
and HMBC (Figure 3.37) spectra, the 13C NMR shifts of all 19 carbons could be obtained 
(Table 3.4). 
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Figure 3.36.  HSQC NMR spectrum of 3.4 in CDCl3. 
The 13C NMR data confirmed the presence of a 1,4-disubstituted phenyl ring in 3.4. In 
the HMBC spectrum of 3.4, the doublet resonance at δH 7.84 showed a correlation with 
a carbonyl carbon resonating at δC 200.5 and also with a sp2- carbon resonating at δC 
164.0. The latter carbon also showed a correlation with one of the methoxy proton 
signals. These observations enabled us to propose the presence of a 4-methoxybenzoyl 
moiety in 3.4. The HMBC correlations also confirm that the second aromatic ring also 
had a methoxy substituent. 
 
Figure 3.37.  HMBC NMR spectrum of 3.4 in CDCl3. 
The NMR data suggested that compound 3.4 might be a diarylpentanoid derivative 
(Celebioglu et al., 2017). Based on the spectroscopic evidence, the structure of 3.4 was 
assigned as 2-hydroxy-5-(3-methoxyphenyl)-1-(4-methoxyphenyl)pentan-1-one, a 
novel diarylpentanoid (Figure 3.38). In order to confirm the structure of 3.4, the NMR 
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data was compared with those reported for diplomorphanone (3.5) (Figure 3.39) 
(Devkota et al., 2012) (for the ‘left-hand’ side of the molecule) and for 3-butylanisole 
(Tietze et al., 2009) for the ‘right-hand side’ of the molecule (Table 3.37). The data 
obtained for 3.4 showed an excellent fit with the published data. 
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Figure 3.38. Structure of compound (3.4). 
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Figure 3.39. Structure of diplomorphanone. 
The UV spectrum of compound 3.4 (Figure 3.40), showed a maximum absorption at λmax 
= 270 nm and this absorption was attributed to the benzene rings in the structure. 
 
Figure 3.40. HPLC UV spectrum of 3.4. 
Diarylheptanoids (two aryl groups connected by a seven-carbon chain) are well known 
compounds and over 400 different derivatives have been isolated, mostly from the 
Zingiberaceae. The most well-known member of this family is curcumin. In contrast, only 
twenty diarylpentanoids have been reported (Celebioglu et al., 2017). From these 20 
compounds, 15 were isolated from the Thymelaeaceae family (Celebioglu et al., 2017). 
The structure of 3.4 is closely related to daphneolone (3.6) (Figure 3.41), the first 
diarylpentanoid to be isolated (Suzuki and Umezawa, 2007). It has been reported that 
the diarylpentanoids isolated from Thymelaeaceae plants have anti-HIV, cytotoxic and 
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insecticidal effects. Considering the interesting biological effects of closely related 
compounds, it would be of interest to investigate the biological activity of 3.4 in a future 
study. 
Table 3.4. 1H (500 MHz) and 13C (125 MHz) NMR data of compound (3.4) in CDCl3. 
Position δC δH δH 
(Devkota et al., 2012) 
δC 
(Devkota et al., 2012)1 
(Tietze et al., 2009)2 
C-1 200.5 -  200.11 
C-4' 164.0 -  161.31 
C-3'' 159.8 -  159.52 
C-1'' 143.8 -  144.62 
C-2'.6' 130.6 7.84 (2H, d, J = 8.9 
Hz) 
7.78 (d, J 8.8 Hz) 131.31 
C-5'' 129.0 7.16 (1H, t, J = 7.8 
Hz) 
6.87 (d, J 8.8. Hz) 129.12 
C-1' 126.4 -  126.11 
C-6'' 120.6 6.70 (1H, dd, J = 
1.7, 7.2 Hz) 
 120.82 
C-2'' 113.9 6.94 (1H, dd, J = 
1.9, 7.0 Hz) 
 114.22 
C-3',5' 113.8 6.94 (1H, dd, J = 
1.9, 7.0 Hz) 
 115.91 
C-4'' 110.9 6.73 (1H, ddd, J = 
2.4, 8.5 Hz) 
 110.62 
C-2 72.3 5.01 (1H, dd, J = 
2.8, 7.5 Hz) 
5.02 (m) 72.51 
4'-OCH3 55.3 3.89 (3H, s)   
3''-OCH3 54.9 3.77 (3H, s)  55.12 
C-4 35.3 1.87 (1H, m) 
1.75 (1H, m) 
1.89 (m) 
1.76 (m) 
33.52 
C-5 35.0 2.64 (1H, m) 
2.57 (1H, m) 
2.63 (m) 35.51 
35.72 
C-3 26.0 1.87 (1H, m) 
1.57 (1H, m) 
1.89 (m) 
1.58 (m) 
35.51 
1Chemical shifts reported for 2-hydroxy-1-(4-hydroxyphenyl)-5-phenyl-1-pentanone 
(dilpomorphanone, 3.5) by Devkota et al. (2009) (Figure 3.38). 
2Chemical shifts reported for 3-butylanisole by Tietze et al. (2009). 
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Figure 3.41. Structure of diplomorphanone. 
Lignans are phenylpropanoid (C6C3) dimers. Based on biosynthetic considerations, 1,5-
diarylpentanoids can be considered as norlignans, i.e. they have one carbon less than 
a lignan. Compound 3.1 can be considered as a C7-C9'-linked norlignan. Suzuki and 
Umezawa (2007) proposed a biosynthetic pathway for norlignans, which is shown in 
Scheme 3.1. 
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Scheme 3.1. Biosynthetic pathway for norlignans. 
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3.2 Antioxidant assay: DPPH radical scavenging activity 
Recent studies found that free radicals cause oxidative damage to biomolecules. The 
damage caused by the free radical induce atherosclerosis, ageing, cancer and other 
diseases (Yamaguchi et al., 1998). Antioxidants which scavenge free radicals play a 
vital role in preventing the free radical-induced diseases (Yamaguchi et al., 1998). The 
common secondary metabolites with antioxidant activity are flavonoids, and anti-
oxidative vitamins such as ascorbic acid and α-tocopherol (Yamaguchi et al., 1998). The 
DPPH assay was used to evaluate the free radical-scavenging activity of an extract of 
the plant. The 2,2-diphenyl-1-picryhydrazyl (DPPH) assay is the most common assay in 
plant biochemistry and it is used for the evaluation of plant constituents for the 
scavenging of free radicals (Gupta et al., 2016). 
In the DPPH assay, the antioxidant activity of a sample is determined by the reduction 
of a stable radical DPPH (λmax 517 nm) to a yellow-coloured diphenyl-picryl hydrazine 
(Scheme 3.1). The results are usually expressed as the IC50 value, which is the amount 
of antioxidant required to decrease the initial DPPH concentration by 50%. In this study 
the different concentration of each plant extract (5, 10, 15, 20 and 25 mg/ml) and 
ascorbic acid(AA) (0.07, 0.14, 0.21, 0.28, and 0.35 mg/ml) were plotted against the 
radical scavenging activity (RSA) percentage to generate the standard curve for each 
plant extract and AA. The IC50 values were calculated from the straight line equation 
from each curve (Gupta et al., 2016). The results of antioxidant scavenging ability of AA 
along with the leaves, root bark, and root extracts of the plant are shown in Table 3.1, 
Table 3.2, Table 3.5 and Table 3.8, respectively. The IC50 values were 0.20 mg/ml (AA), 
14.57 mg/ml (leave extract), 15.47 mg/ml (root bark extract), and 16.59 mg/ml (root 
extract). The results for each research sample show that the %RSA of each sample was 
directly proportional to the concentration (Thaipong et al., 2006).  
N N NO2
NO2
N NH NO2
NO2
R:H R+ +
DPPH DPPH-H  
Scheme 3.2. Scavenging the DPPH Radical by an antioxidant. 
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Table 3.5. The radical scavenging activity of ascorbic acid at different concentrations 
against the DPPH stable free radical 
Sample 
volume 
(µL) 
Blank 
Absorbance 
Extract 
Absorbance 
Extract 
concentration 
(mg/mL) 
%RSA IC50 
(mg/ml) 
200 0.99264 0.74606 0.07 24.84  
0.20 400 0.99264 0.64171 0.14 35.093 
600 0.99264 0.50312 0.21 48.952 
800 0.99264 0.32576 0.28 66.688 
1000 0.99264 0.10752 0.35 88.512 
 
Figure 3.42. The relationship between the radical scavenging activity of ascorbic acid 
in different concentrations by DPPH assay. 
Table 3.6. The radical scavenging activity of leave extract of Dais cotinifolia at different 
concentrations against the DPPH stable free radical. 
Sample 
volume 
(µL) 
Blank 
Absorbance 
Extract 
Absorbance 
Extract 
concentration 
(mg/mL) 
%RSA IC50 
(mg/ml) 
200 0.99264 0.82462 5 16.9  
14.57 400 0.99264 0.61859 10 37.7 
600 0.99264 0.50786 15 48.8 
800 0.99264 0.32291 20 67.5 
1000 0.99264 0.13723 25 86.2 
y = 227.06x + 5.1353
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Figure 3.43. The radical scavenging activity MeOH leave extract of D. cotinifolia in 
different concentrations by means of DPPH assay. 
Table 3.7. The radical scavenging activity of root bark extract of Dais cotinifolia at 
different concentrations against the DPPH stable free radical. 
Sample 
volume 
(µL) 
Blank 
Absorbance 
Extract 
Absorbance 
Extract 
concentration 
(mg/mL) 
%RSA IC50 
(mg/ml) 
200 0.99264 0.85606 5 13.6  
15.47 400 0.99264 0.69171 10 30.3 
600 0.99264 0.52312 15 47.3 
800 0.99264 0.32676 20 67.1 
1000 0.99264 0.16752 25 83.1 
 
Figure 3.44. The relationship between the radical scavenging activity MeOH root bark 
extract of D. cotinifolia in different concentrations by means of DPPH assay. 
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Table 3.8. The radical scavenging activity of root extract of Dais cotinifolia at different 
concentrations against the DPPH stable free radical. 
Sample 
volume 
(µL) 
Blank 
Absorbance 
Extract 
Absorbance 
Extract 
concentration 
(mg/mL) 
%RSA IC50 
(mg/ml) 
200 0.99264 0.85606 5 8.5  
16.59 400 0.99264 0.69171 10 20.6 
600 0.99264 0.52312 15 42.2 
800 0.99264 0.32676 20 68.9 
1000 0.99264 0.16752 25 79.6 
  
Figure 3.45. The relationship between the radical scavenging activity MeOH root 
extract of D. cotinifolia in different concentrations by means of DPPH assay. 
The ascorbic acid had a higher radical scavenging ability (Figure 3.42) as compared to 
the crude extract followed by the leaves crude extract, root bark extract and then the 
roots, the evidence is exhibited by the IC50 values (listed above). This means that the 
plant extracts are required at a higher concentration as compared to the ascorbic acid 
to scavenge the DPPH stable free radical. Therefore, ascorbic acid was observed to be 
a better antioxidant than the plant extract. When comparing the plant extracts, the 
evidence pointed out that the leaf extract had a better antioxidant activity than the other 
parts of the plant. Nonetheless, there was no much difference in the antioxidant activity 
between the plant extracts. The differences between the leaves and root bark were 0.9 
mg/ml and 2.02 mg/ml between the leaves and the roots. Furthermore, when looking at 
the plant extracts at a concentration of 5 mg/ml, the leaf extracts could scavenge 16.9% 
of DPPH, root bark extract scavenged 13.6% and the root extract scavenged 8.5%. At 
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a concentration of 15 mg/ml,  the leaves scavenged 48.8%, the root bark scavenged 
47.8% and the roots scavenged 42.2%. From this observation it was noticed that the 
leaves had a better antioxidant activity as compared to the other parts of the plant, 
followed by the root bark and then the roots. Nevertheless, all the different parts of the 
plant had antioxidant activity (Gupta et al., 2016) (Figure 3.43-3.45). 
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Chapter 4: Experimental 
4.1 General Experimental Procedures 
Extraction and chromatography were performed with analytical grade dichloromethane 
(DCM), ethyl acetate (EtOAc), and methanol (MeOH). Hexanes (Hex) (a mixture of 
hexane isomers) were distilled before use. Water used always refers to distilled water. 
4.1.1 Thin-Layer Chromatography (TLC) 
Aluminum-backed thin-layer chromatography (TLC) plates (Silica gel 60 F254, 0.25 mm, 
Merck) were used for the detection of different components in extracts and to select 
solvent systems for column chromatography and preparative centrifugal thin-layer 
chromatography (PCTLC). A TLC plates (stationary phase) would be introduced into a 
particular solvent system (mobile phase) for the detection of various components in an 
extract. The separation of the components was then examined under ultraviolet (UV) 
light at two different wavelengths, a short wavelength (254 nm) and a long wavelength 
(365 nm). To detect the components in a sample that do not absorb UV, the plate was 
sprayed with a reactive stain reagent, i.e. anisaldehyde stain reagent. The anisaldehyde 
stain reagent was prepared by introducing 84 mL of MeOH in a 250 mL volumetric flask 
in an ice bath. While continuously shaking and maintaining a low temperature, the 
following reagents were added sequentially: acetic acid (100 mL), sulfuric acid (40 mL, 
dropwise) and anisaldehyde (5 mL, dropwise). The homogenous mixture was stored in 
a fridge. 
4.1.2 DIOL SPE Chromatography 
Applied Separations SPE Diol column (2 g/6 mL) were used for analytical fractionation 
of crude extracts. A crude extract was fractionated into five different fractions by eluting 
the sample components with solvents of increasing polarity. The C18 DIOL served as a 
stationary phase in which the silica is derivatised with 1,2-dihydroxypropane. To run a 
DIOL column, 100 mg of extract dissolved in 1 mL of a DCM-MeOH (1:1) mixture was 
deposited onto the DIOL column. The solution was allowed to percolate down the 
column and was allowed to dry for 24 h. The following day a slight vacuum was applied 
to the column for at least 15 minutes ensuring that the residual solvent was removed. 
Sequential elution was then performed with 12 mL of each of the following solvents with 
increasing polarity, Hex-DCM (9:1), DCM-EtOAc (20:1), EtOAc, EtOAc-MeOH (5:1), and 
MeOH. 
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4.1.3 Vacuum Liquid Chromatography (VLC) 
Vacuum Liquid Chromatography (VLC) is similar to DIOL SPE chromatography 
regarding analytical fractionation, but this method was used for fractionation of larger 
amounts of crude extracts. The crude extract was divided into five fractions. The solvent 
systems that were used for fractionation were similar to the solvent systems that were 
used for the DIOL fractionation, but sequential elution was performed with 200 mL of 
each solvent system. The stationary phase in the VLC was silica gel 60 (40-63 μm, 
Merck). With a VLC column, 30 g of silica gel was used for every 1 g of the sample.  
4.1.4 Liquid-Liquid Extraction 
Liquid-Liquid extraction was performed to isolate the extract components according to 
polarity. A summary of the procedure is given in Figure 4.1 below. 
 
Figure 4.1. Summary of liquid-liquid extraction. 
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4.1.5 Column Chromatography (CC) 
Column Chromatography (CC) is an analytical method that was used for the isolation of 
a mixture of compounds. CC was performed on a glass column packed with silica gel 
60 (40-63 μm, Merck) as the stationary phase.  To pack the column, a silica gel slurry 
was loaded into the glass column, followed by the sea sand to separate the sample from 
the silica gel, sample (pre-adsorbed in silica gel 60), and then the sea sand to prevent 
the solvent from disturbing the sample layer. Sequential isolation based on the polarity 
of solvents was performed to separate the components of a sample or extracts. Figure 
4.2 is the summary of a general procedure for column chromatography that was followed 
in the isolation of compounds from different plant extracts. 
 
Figure 4.2. The general procedure for column chromatography. 
4.1.6 Preparative Centrifugal Thin-layer Chromatography (PCTLC) 
Preparative Centrifugal Thin-Layer Chromatography (PCTLC) combines the advantages 
of both TLC and CC, and this method was used to isolate compounds from smaller 
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amounts of mixtures. PCTLC was performed on a Harrison Research Chromatotron™, 
model ENF-280 C/F. The rotor was coated with a mixture of silica gel 60 PF254 containing 
gypsum (Merck) and dried in an oven at 50 ºC before use. For 1 mm thickness, 45 g of 
silica was mixed with 90 mL of distilled water, for 2 mm thickness 65 g of silica was 
mixed with 130 mL of distilled water, and for 4 mm thickness, 115 g of silica was mixed 
with 230 mL of distilled water.  
The sample was dissolved in a small volume of eluting solvent before it was applied to 
the spinning plate. The eluting solvent was delivered by gravity from a container that 
was lifted about 70 cm above the rotor and flow through an inlet stopper marked 1, 2 or 
4, following the thickness of the silica layer. Separation was achieved through gradient 
or isocratic elution based on the TLC profile. The moving bands were visualised using 
UV light at λ 254 or λ 365 nm. Small fractions were collected (Desai et al., 1985). 
4.1.7 High-Performance Liquid Chromatography (HPLC) 
High-Performance Liquid Chromatography (HPLC) is an analytical method that was 
used for analysis of small quantities of compound mixtures. Analyses were performed 
on a SHIMADZU HPLC, CBM-20A communication bus module, LC-20AB prominence 
liquid chromatography, SIL-20A prominence autosampler, and SPD-M20A prominence 
diode-array detector. A 200 ppm sample was prepared with an HPLC analytical solvent. 
The solution was injected onto a LUNA 5µ C18 (2) (250 x 4.60 mm, 5µ) column. The 
sample was eluted using the following a standard gradient method, as shown in Table 
4.1 below. 
Table 4.1. Standard gradient method used for HPLC. 
Time (minutes) % MeOH: ACN: 
FA (4: 3: 0.1) 
% Ultrapure water with 0.1 % 
formic acid 
0.01 40 60 
28 100 0 
35 100 0 
38 40 60 
42 Stop stop 
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4.1.8 Liquid Chromatography-Mass Spectrometry (LC-MS) 
A SHIMADZU LCMS-2020 with a quadrupole mass detector was used for the 
characterisation of compounds in terms of spectrum and mass determination. A 200-
ppm solution of crude samples was injected onto a Shim-pack GIST (3 µm C18-HP, 4.6 
x 150 mm) column and eluted with solvents of different polarity. For a pure compound, 
a 10 ppm solution was injected. 
4.1.9 Nuclear Magnetic Resonance (NMR) Spectroscopy 
Nuclear Magnetic Resonance (NMR) Spectroscopy was used for the characterisation of 
pure compounds. The NMR spectra were recorded on a Bruker Avance III 500 
(operating at 500 MHz for 1H and 125 MHz for 13C) or a Bruker Avance III 400 (operating 
at 400 MHz for 1H and 100 MHz for 13C) spectrometers. The NMR experiments that were 
used for structural elucidation were 1H, 13C, DEPT-135, COSY, NOESY, HSQC and 
HMBC. All spectra were recorded in deuterated chloroform and methanol at 30 ºC using 
a 5 mm BBOZ probe or 5 mm TBIZ probe. Chemical shifts (δ) are given in part per million 
(ppm) relative to tetramethylsilane, TMS (δ = 0) and are referenced to residual 
protonated solvent peaks, for CDCl3: 1H = δ 7.26, 13C = δ 77.0 and CD3OD: 1H δ 3.31, 
13C δ 49.1. The multiplicities of peaks were abbreviated as follows; s = singlet, d = 
doublet, dd = doublet of doublets, ddd = doublets of doublets of doublets, t = triplet, dt = 
doublet of triplet and m = multiplet. Coupling constant (J) are given in Hz. A 10 mg/ 0.5 
mL sample was prepared for 1H NMR, and a 20 mg/0.5 mL sample was prepared for 13C 
NMR. 
4.1.10 Time-of-Flight Mass Spectrometry (TOFMS) 
An LCT Premier Time-of-flight Mass Spectrometer (TOF-MS) from MICROMASS 
TECHNOLOGIES was used for the determination of the accurate mass of a compound. 
TOF-MS (time-of-flight mass spectrometry) is a type of a high-resolution mass 
spectrometry. The ionisation used was  electrospray ionisation (ESI) either in the 
positive mode or negative (Breitkopf et al., 2017). 
4.1.11 Ultraviolet (UV)-Vis Spectroscopy  
A Cary 100 UV-Vis spectrometer from Agilent Technology was used to determine the 
spectrum of a pure compound. The ultraviolet (UV) spectrometer characterises organic 
compounds with conjugated double bonds (Bruice, 2014). The absorption of the 
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compound was recorded at different concentrations. All the spectra were recorded at a 
UV range of 180-400 nm. 
4.2 Extraction and Isolation 
4.2.1 Plant Material 
Plant material of D. cotinifolia was collected in the UKZN Botanical Garden, University 
of KwaZulu-Natal, Pietermaritzburg, on the 19th of April 2016. The plant was identified 
by Ms Alison Young, curator of the UKZN Botanical Garden.  A voucher specimen (B. 
Danca1 (NU)) was prepared and deposited in the Bews Herbarium, School of Life 
Sciences, UKZN.  
The various parts of the plant (leaves, branches, roots and root barks) were separated, 
any soil particles removed from the plant material, and plant parts dried at room 
temperature for two to three weeks. The dry material was ground with a hammer mill. 
The masses of the dry materials are shown in Table 4.2. 
Table 4.2. Mass of dry plant material. 
Plant material  Dry powdered 
Mass (g) 
Description 
Leaves 529 Green powder 
Branches 544 Light-brown 
powder 
Roots 616 Light-brown 
powder 
Root barks 950 Brown powder 
 
4.2.2 Preparation of Crude Extracts  
The powdered plant materials [leaves (529 g), branches (544 g), roots (616 g) and root 
bark (950 g)] were extracted sequentially with DCM, DCM-MeOH (1:1) and MeOH. The 
plant material was first submerged in DCM and then left on an orbital shaker (120 rpm) 
at 23 ºC for 24 h. The plant material was filtered, and the solvent was removed under 
vacuum with a rotavapor to yield a crude DCM extract; this process was repeated, and 
the two DCM extracts were combined. The recovered plant material was left to dry at 
room temperature, DCM-MeOH (1:1) mixture was added to the plant material and the 
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mixture left on an orbital shaker (120 rpm) at 23 ºC for 24 h. The material was filtered, 
and the solvents removed under vacuum using a rotavapor to yield a crude DCM-MeOH 
extract. This process was repeated, and the extract combined with the first DCM-MeOH 
extract. The recovered plant material was dried at room temperature, MeOH was added, 
and the mixture was left on an orbital shaker (120 rpm) at 23 ºC for 24 h. The contents 
were filtered, and the solvent was evaporated using a rotavapor to yield the MeOH crude 
extract. This extraction was also repeated a second time, and the two MeOH extracts 
were combined. The masses of the crude extracts are shown in Table 4.3. 
Table 4.3. Mass of crude extracts of different plant parts. 
Plant material Solvents Weight of dry 
material (g) 
Weight of 
extracts (g) 
Description Fraction 
Leaves DCM 10  0.399  BBD-1-5A 
 DCM-MeOH 10  
50  
0.650 
5.874 
 BBD-1-7B 
BBD-1-11A 
 MeOH 10  
50  
0.603 
2.718 
 BBD-1-8B 
BBD-1-11B 
Leaves mass 
extraction  
DCM 
DCM-MeOH 
MeOH 
 
450 
42.315 
14.493 
14.810 
Dark green 
Dark green 
Dark green 
BBD-1-15A 
BBD-1-15B 
BBD-1-15C 
      
Branches DCM-MeOH 50  3.744  BBD-1-15D 
 MeOH 50  1.693  BBD-1-15E 
Branches mass 
extraction 
DCM-MeOH 
MeOH 
470  23.234 
13.934 
Brown 
Dark brown 
BBD-1-27A 
BBD-1-27B 
      
Roots DCM 10  0.079  BBD-1-5A 
 DCM-MeOH 10  
50 
0.293 
2.024 
 BBD-1-7A 
BBD-1-21A 
 MeOH 10  
50  
0.603 
1.997 
 BBD-1-8A 
BBD-1-21B 
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Roots mass 
extraction  
DCM-MeOH 
MeOH 
550 7.933 
6.878 
Brown 
Dark brown  
BBD-1-40A 
BBD-1-40B 
      
Root barks DCM 10  0.209  BBD-1-5C 
 DCM-MeOH 10  
50  
0.852 
6.516 
 BBD-1-7C 
BBD-1-17A 
 MeOH 10  
50  
0.603 
4.905 
 BBD-1-8C 
BBD-1-17B 
Root barks mass 
extraction 
DCM-MeOH 
MeOH 
885 42.296 
25.124 
Light brown 
Dark brown 
BBD-1-47A 
BBD-1-47B 
 
4.2.3 Isolation of Pure Compounds 
A DCM leave extract (BBD-1-50A) of D. cotinifolia (4.128 g) was subjected to VLC on 
120 g silica gel. Five fractions, BBD-1-54A to BBD-1-54E, were obtained after 
performing sequential elution with the solvent systems described in Section 4.1.3. The 
yields of the fractions were BBD-1-54 A (54 mg), B (1.162 g), C (1.581 g), D (43 mg) 
and E (245 mg). A TLC analysis was performed on the fractions and fraction B and C 
were investigated further.  Fraction BBD-1-54 C was subjected to VLC on 30 g of silica 
gel eluting with solvents of increasing polarity, Hex-EtOAc (8:2), (7:3), (6:4), (1:1), (4:6), 
(7:3), (2:8), EtOAc, and MeOH. A TLC profile was performed, and fractions with the 
same compounds according to the Rf values were combined. Further isolation on 2 mm 
CTLC plate was performed for BBD-1-57G (73 mg), with an isocratic solvent system of 
hexane: Hex: EtOAc (6:4), which yielded 14 mg of kobusin (3.1).  
Similar to the above: A MeOH leaf extract (BBD-1-50C) of D. cotinifolia (12.114 g) was 
subjected to VLC on 200 g silica gel. Five fractions were obtained with the solvent 
systems described in Section 4.1.3. The yields of the fractions were BBD-1-67A (11 mg), 
B (513 mg), C (648 mg), D (537 mg) and E (9.448 g). After performing TLC analysis, 
fractions with the same Rf values were combined, and BBD-1-67C was further purified 
on a 4 mm CTLC plate. A TLC analysis was performed on the fractions, and the fractions 
were combined based on the Rf values. Fraction BBD-1-70B (combination of the BBD-
1-67C fractions) was subjected to PCTLC on a 1 mm Chromatotron™ plate and eluted 
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with an isocratic mixture of hex: EtOAc (6:4), yielding BBD-1-70B2 (17 mg), which both 
contain eudesmin (3.2). 
A DCM-MeOH root bark extract (BBD-1-71A) of D. cotinifolia (12.046 g) was subjected 
to VLC on 200 g of silica gel. Five fractions, BBD-1-73A-E were obtained with Hex-DCM 
(9:1), DCM-EtOAc (20:1), EtOAc, EtOAc-MeOH (5:1) and MeOH as solvent systems. 
The yields of the fractions were A (11 mg), B (251 mg), C (469 mg), D (752 mg) and E 
(8.755 g). BBD-1-73 B (125 mg) was subjected to PCTLC on a 4 mm plate with an 
isocratic solution, hex-EtOAc (7:3), which yielded BBD-1-75I (3 mg), which was also 
identified as eudesmin (3.2). 
A MeOH root bark extract (BBD-1-71B) of D. cotinifolia (12.001 g) subjected to VLC on 
200 g silica gel. Five fractions were obtained from the following solvent systems, Hex-
DCM (9:1), DCM-EtOAc (20:1), EtOAc, EtOAc-MeOH (5:1) and MeOH. The yields of the 
fractions were BBD-1-84C (8 mg), D (313 mg), E (367 mg), F (197 mg) and G (6.164 g), 
respectively. After considering the TLC profile, fractions with the same Rf values were 
combined, and BBD-1-84E was fractionated further on a small column with 3 g of silica 
gel. TLC analysis was performed on the fractions, and the fractions were mixed based 
on the Rf values. The sample was further isolated on a preparative plate (TLC) using 
DCM-MeOH (9:1) as a solvent system yielding BBD-1-92A (5mg), which was 
characterised as catechin (3.3).  
The crude DCM extract of leaves of D. cotinifolia BBD-1-50A (4.128 g) was fractionated 
on a VLC column. Five fractions were obtained from the following solvent systems, Hex-
DCM (9:1), DCM-EtOAc (20:1), EtOAc, EtOAc-MeOH (5:1) and MeOH. The yield of the 
fraction was as follows; BBD-1-54A (54 mg), B (1.162 g), C (1.581 g), D (43 mg), and E 
(245 mg) respectively. TLC analysis was performed, and a further fractionation was 
performed on fraction B. 100 mg of BBD-1-54B was dissolved into a DCM-MeOH (1:1) 
solvent and left to percolate down the DIOL SPE column for 24 h. The extract was then 
fractionated with the solvent systems that were used on VLC.  The yields of the fractions 
were BBD-1-104A (30.1 mg), B (40.6 mg), C (9.6 mg), D (3.9 mg) and E (4.2 mg). After 
TLC analysis, fraction BBD-1-104B was taken for assessment on HPLC. A 40.6 mg of 
BBD-1-104B fraction was dissolved in HPLC grade MeOH (1 mL), sonicated for 5 min 
in a SCIENTECH ultrasonic bath. The solution was then filtered through a C8 SPE 
cartridge under vacuum.  Multiple injections of 200 µL of the extract were performed in 
HPLC using the standard gradient method (in the experimental section) yielding BBD-1-
104B2 (2.5 mg) which was compound (3.4). The extraction summary of all the 
compounds is shown in Figure 4.3. 
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Figure 4.3. Extraction summary. 
 
The physical data for the pure compounds:  
Physical data of kobusin (3.1) 
Physical description: White powder 
Yield:   14 mg 
TOF-MS: 393.1 
Molecular formula: C22H22O6 
NMR data:  
1H NMR:  Plate 1A 
13C NMR:  Plate 1B 
DEPT:  Plate 1C 
COSY:  Plate 1D 
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HSQC:  Plate 1E 
HSQC:  Plate 1F (Ar-HSQC) 
HMBC:  Plate 1G 
HMBC:  Plate 1H (Ar-HMBC) 
Physical data of eudesmin (3.2) 
Physical description: White powder 
Yield:   17 mg 
TOF-MS: 409.3 
Molecular formula: C22H26O6 
NMR data:  
1H NMR: Plate 2A 
13C NMR: Plate 2B 
DEPT:  Plate 2C  
COSY:  Plate 2D 
HSQC:  Plate 2E 
HMBC:  Plate 2F 
Physical data of catechin (3.3) 
Physical description: Yellow powder 
Yield:   5 mg 
MS:  291  
Molecular formula: C15H14O6  
NMR data:  
1H NMR:  Plate 3A 
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13C NMR: Plate 3B 
DEPT:  Plate 3C  
COSY:  Plate 3D 
HSQC:  Plate 3E 
HMBC:  Plate 3F 
Physical data of compound 3.4 
Physical description: White powder 
Yield:   2.5 mg 
TOF-MS: 337.1 
Molecular formula:  
NMR data:  
1H NMR:  Plate 4A 
COSY:  Plate 4B 
HSQC:  Plate 4C 
HMBC:  Plate 4D 
 
4.3 Biological Assay 
4.3.1 DPPH Radical Scavenging Assay   
This experiment was carried out according to Shivashankara et al., 2004.  
Preparation of stock solutions 
1 mM DPPH methanolic stock solution: 0.0049 g of DPPH was dissolved in 12.5 mL 
of methanol in the dark and stored at -20 ºC before use. 
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0.1 mM DPPH working solution (10x dilution): 10 mL of the stock solution was mixed 
with 90 mL of methanol and was used immediately.  
2 mM ascorbic acid (AA) standard solution: 0.0035 g of AA was dissolved in 10 mL 
of methanol. Dilutions of AA in a 2 mL centrifuge tube was prepared as indicated in Table 
4.4 below. 
 
Table 4.4. Prepared dilutions of ascorbic acid (AA). 
 
Concentration 
(mg/mL) 
2 mM AA (µL) Methanol (µL) Final volume 
(µL) 
Std1 0 0 1000 1000 
Std2 0.07 200 800 1000 
Std3 0.14 400 600 1000 
Std4 0.21 600 400 1000 
Std5 0.28 800 200 1000 
Std6 0.35 1000 0 1000 
Sample preparation: For each crude extract (leaves, root bark and roots MeOH 
extracts) of D. cotinifolia, the following procedure was followed. The extract (0.5 g) was 
dissolved in 10 mL of methanol using an Ultra Turrax ® T25 basic homogeniser (IKA 
Works, Willmington NC). The mixture was then sonicated for 30 minutes in a CHECK 
(Bransonic Ultrasonic Co. Danbury, CT) and centrifuged at 10 000 rpm for 10 min at 4 
°C. The aliquot was collected and stored at -26 °C before analysis with 2,2-diphenyl-1-
picrylhydrazyl (DPPH).  
200 µL of each standard extract was added into a clean cuvette, 800 µL of methanol 
was added to each tube, and then 1 mL of 0.1 mM DPPH solution was added to each 
tube in the dark, covered with aluminium foil and allowed to stand for 60 min at room 
temperature. The absorbance was measured at 517 nm against the blank (methanol) 
under dim light. Table 4.5 below, shows the dilutions of different plant extracts.  
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Table 4.5. The standard stock solutions of different parts of the plant extract (leaves, 
root bark, and roots) were diluted into 2 mL centrifuge tubes as follows: 
 
Extracts 
concentration 
(mg/mL) 
Extract (µL) Methanol (µL) Final volume 
(µL) 
Std1 0 0 1000 1000 
Std2 5 200 800 1000 
Std3 10 400 600 1000 
Std4 15 600 400 1000 
Std5 20 800 200 1000 
Std6 25 1000 0 1000 
A 0.1 mM DPPH solution in methanol was prepared and 1 mL of the solution was added 
to 1 mL of the sample. After shaking the mixture vigorously, it was allowed to remain at 
room temperature in the dark for 30 minutes. The absorbance of each mixture was 
measured in triplicates at 517 nm using a UV Shimadzu UV-1800 spectrometer. 
Ascorbic acid (AA) was used as the standard because of its intense reducing power and 
a weak metal chelating ability. The absorbance was measured at different 
concentrations of AA as depicted in Table 4.4. The IC50 was calculated using different 
concentrations of the extracts/ascorbic acid versus radical scavenging capacity curve. 
The IC50 value is the concentration of an analyte or sample that is needed to inhibit 50% 
of the DPPH free radicals.   The free radical scavenging activity was observed by the 
discolouration of the DPPH solution. The percentage DPPH scavenging effect of each 
extract was calculated by the following equation: 
% 𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅𝑅 𝑆𝑆𝑅𝑅𝑅𝑅𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑆𝑅𝑅𝑆𝑆𝑆𝑆 𝐴𝐴𝑅𝑅𝐴𝐴𝑅𝑅𝑆𝑆𝑅𝑅𝐴𝐴𝐴𝐴 = 𝐴𝐴𝐴𝐴𝐴𝐴 (𝐴𝐴𝑅𝑅𝑅𝑅𝑆𝑆𝑏𝑏) − 𝐴𝐴𝐴𝐴𝐴𝐴(𝑆𝑆𝑒𝑒𝐴𝐴𝑡𝑡𝑅𝑅𝑅𝑅𝐴𝐴)
𝐴𝐴𝐴𝐴𝐴𝐴 (𝐴𝐴𝑅𝑅𝑅𝑅𝑆𝑆𝑏𝑏) × 100 
The blank was the absorbance without the extract or AA. Extract indicated the 
absorbance that was taken in the presence of an extract or AA. Abs denoted the 
absorbance.  
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Chapter 5: Conclusion 
In this thesis, a phytochemical investigation of the tree Dais cotinifolia (Thymelaeaceae) 
is described in detail. Many bioactive compounds have been isolated from the 
Thymelaeaceae, such as prostratin (potent anti-HIV agent) and antitumour diterpenoids. 
Although a large number of  Thymelaeaceae species are indigenous to South Africa, 
only a limited number of species have been subjected to phytochemical investigations. 
Dais cotinifolia L. is one species on which phytochemical results have not been 
published and this tree was the subject of this investigation. 
Four compounds were isolated from the different parts of the plant, two furofuran lignans, 
kobusin (3.1) and eudesmin (3.2), a flavonoid, catechin (3.3), and a novel norlignan 
(3.4). The antioxidants activities in plants extracts are often associated with the presence 
of phenolic compounds. Catechin (3.1) is a known antioxidant. The two lignans and the 
norlignan only have methoxy substituents on the phenyl rings and there are no free 
hydroxy groups.  The lack of free hydroxy groups on the major compounds may explain 
the relatively low antioxidant activity observed for the crude extracts of the different plant 
parts of D. cotinifolia.  
Lignans are known to have anticancer and anti-HIV activity. The norlignans are 
associated with a variety of biological activities. Advanced biological assays were not 
part of this investigation but the compounds isolated, especially the novel norlignan need 
to be assessed for their biological acvtivities. 
Future work should include 
• The isolation of larger amounts of compounds 
• The reinvestigation of the extracts for the presence of the interesting norlignans 
• Determination of the biological activity of the compounds 
• The relatively simple structure of the norlignan may lead to the synthesis of this 
compound and synthetic analogues for bioactivity assays. 
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Plate 1A. 1H NMR spectrum of kobusin (3.1) in CDCl3 at 400 MHz. 
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Plate 1B. 13C NMR spectrum of kobusin (3.1) in CDCl3 at 100 MHz.  
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Plate 1C. DEPT 135 NMR spectrum of kobusin (3.1) in CDCl3 at 100 MHz. 
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Plate 1D. COSY NMR spectrum of kobusin (3.1) in CDCl3. 
O
O
O
O
O
O
H3C
H3C
1
2
3
4
5
6
7
89
9'8'
7'
5'
6' 4'
3'
2'1'H
H
H
H
H
H
 
 
 
 
 
 
ppm
8 7 6 5 4 3 2 1 ppm
1
2
3
4
5
6
7
8
  
95 | P a g e  
 
Plate 1E. HSQC NMR spectrum of kobusin (3.1) in CDCl3. 
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Plate 1F. HSQC NMR aromatic region spectrum of kobusin (3.1) in CDCl3.  
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Plate 1G. HMBC NMR spectrum of kobusin (3.1) in CDCl3.  
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Plate 1H. HMBC NMR aromatic region spectrum of kobusin (3.1) in CDCl3. 
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Plate 2A. 1H NMR spectrum of eudesmin (3.2) CDCl3 at 400 MHz. 
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Plate 2B. 13C NMR spectrum of eudesmin (3.2) in CDCl3 at 100 MHz. 
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Plate 2C. DEPT NMR spectrum of eudesmin (3.2) in CDCl3 at 100 MHz. 
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Plate 2D. COSY NMR spectrum of eudesmin (3.2) in CDCl3. 
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Plate 2E. HSQC NMR spectrum of eudesmin (3.2) in CDCl3. 
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Plate 2F. HMBC NMR spectrum of eudesmin (3.2) in CDCl3. 
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Plate 3A . 1H NMR spectrum of catechin (3.3) in CD3OD at 400 MHz. 
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Plate 3B. 13C NMR spectrum of catechin (3.3) in CD3OD at 100 MHz. 
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Plate 3C. DEPT NMR spectrum of catechin (3.3) in CD3OD at 100 MHz. 
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Plate 3D. COSY NMR spectrum of catechin (3.3) in CD3OD. 
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Plate 3E. HSQC NMR spectrum of catechin (3.3) in CD3OD. 
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Plate 3F. HMBC NMR spectrum of catechin (3.3) in CD3OD. 
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Plate 4A. 1H NMR spectrum of compound 3.4 in CDCl3 at 500 MHz. 
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Plate 4B. COSY spectrum of compound 3.4 in CDCl3 at 500 MHz. 
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Plate 4C. HSQC spectrum of compound 3.4 in CDCl3. 
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Plate 4D. HMBC spectrum of compound 3.4 in CDCl3. 
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